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ABSTRACT 
 The current biological toolkit has been vital in advancing our understanding of the 
world. That being said, the toolkit has limitations. As such, chemical biologists have been 
developing novel means to probe biological systems using chemical techniques. 
Bioorthogonal chemistry represents a new avenue to address biological questions that 
cannot be answered using current techniques. Herein, we describe a novel technique to 
probe proteins-of-interest using unnatural amino acid (UAA) mutagenesis. We have found 
that our UAAs allow us to access bioorthogonal chemistries for the conjugation of 
fluorophores to UAA-containing proteins. Additionally, we have extended these findings 
towards the application of protein immobilization. Finally, we used microwave technology 
to investigate novel means to transform bacterial cells with exogenous DNA.  
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CHAPTER 1: INTRODUCTION TO THE UNNATURAL AMINO ACIDS 
AND BIOCONJUGATIONS 
 
 
In the sequential arrangement of amino acids that form proteins, nature has 
achieved elegant macromolecules with properties chemists have yet to fully replicate.1 
Based on their biological functions, proteins can both bind small molecules with incredibly 
high affinities and catalyze reactions with ease that often require harsh conditions in vitro. 
Based on these characteristics, harnessing the power of proteins would allow scientists to 
develop novel diagnostic and catalytic tools that would advance science. Additionally, 
these unique properties of proteins make them responsible for the myriad of cellular 
functions that enable living systems to exist. As such, molecular biology has been 
revolutionized by the ability to study and observe proteins in vivo. Thus, the study of 
proteins and their development towards novel technologies is a crucial area of science that 
constantly requires additional innovations.  
For example, a serious issue facing researchers wishing to fight cancer is 
discovering new ways to accurately detect the presence of cancer within patients. Nature 
recently published a report detailing the use of fluorescent probes as a means of live 
imaging cancer cells during surgery based on the presence and detection of certain 
proteins.2 The results of such technology will enhance removal of malignant tissue while 
decreasing relapse rates and damage to patient’s healthy tissue. Accordingly, fluorescent 
molecular imaging is proving to be a key player in the war against cancer, and while it has 
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come a long way, there are limitations that must be overcome before such specialized 
applications become widespread.  
Common fluorescent-imaging techniques rely on either small fluorescent dyes or 
fluorescent proteins to serve as labels. These methods often require either the diffusion of 
an excess of fluorescent molecules into the sample organism or extensive genetic 
manipulation of the organism’s genome to fuse fluorescent proteins to the protein of 
interest.3 Immunolabeling techniques, which rely on the very specific binding of an 
antibody-fluorophore complex to a specific cellular structure, are often confounded by high 
background fluorescence due to non-specific binding. Genetic tagging of proteins relies on 
the extensive manipulation of the organism’s genome, and involves the incorporation of a 
large fluorescent protein moiety into the protein of interest. By altering the protein’s 
structure, genetic tagging risks rendering the protein inactive or altering its normal 
function. In addition, the fluorescence signal produced is constant and cannot be controlled 
by the researcher. Thus, the vital importance of studying proteins in molecular biology 
necessitates that scientists evolve new means to image proteins. 
Another emerging field involving proteins is the development of protein biochips. 
These biochips contain dense spots, or microarrays of thousands of diverse or homogenous 
proteins immobilized on a solid support.4,5 They offer the potential to harness the unique 
power of protein chemistry. For example, such technology can allow for the rapid and high-
throughput screening of thousands of macromolecules of biological interest, allowing for 
the rapid discovery of new drug candidates. Similar to the Nature paper above, such 
protein-based technology can be directly applied to diagnostics, such as detecting cancer 
9 
 
markers in blood.6,7 Due to their high affinity for their substrate, protein chips would allow 
for the rapid and sensitive detection of biomolecules and toxins.  
Despite their promise, protein-based chips are still a nascent technology, being 
highly limited by current immobilization techniques. Many of these involve simple 
adsorption onto a surface, which may not provide a robust chip for utilization.5 In this 
technique, proteins are adsorbed onto a surface via ionic or hydrophobic interactions. 
Because of the potential for multiple interacting sites, the result is often a heterogenous 
layer with a random protein orientation. This is disadvantageous, as the protein may not be 
correctly oriented to perform the desired function. Covalent bonding to the support is often 
the most ideal mechanism to ensure an irreversible attachment. By reacting a functionalized 
support with key amino acid residues, such as lysine or cysteine residues that respectively 
contain amine and thiol functionalities, more robust attachements can be made.  However, 
these amino acid side chain bonding strategies can occur at multiple sites, resulting in 
proteins that may either be conformationally inactive or also inappropriately oriented to 
bind molecules of interest.5 Bioaffinity based attachment, in which key protein structures 
or properties are exploited to bind a high affinity ligand, such as another protein (i.e. 
antibody), is an option that can allow for the binding of proteins in specific orientations. 
However, this technique relies on non-covalent binding, and is thus less robust. 
Furthermore, it limits the number of proteins that can be bound to the surface, since proteins 
must have particular structures or properties in order to interact with the ligand.  
10 
 
 
Figure 1. There are numerous methods for immobilizing proteins on a solid support. Covalent attachment of the protein 
represents the most robust technique, although it is often complicated by the presence of multiple reaction partners on 
a single peptide. Adapted Rusmini et al.5 
Before this biochip technology can become widespread, scientists must solve these 
immobilization problems. Additionally, the need to find new ways to probe protein 
structure and function also creates the need to develop new ways to manipulate protein 
structure and function. A potential alternative to both of these areas involves the application 
of unnatural amino acid technology.  
Unnatural amino acids (UAAs) allow scientists to expand the rather limited 
biochemical functionality found in the 20 canonical amino acids and introduce novel 
reactivity not typically found in proteins.3,8 Incorporated via suppression of a TAG stop 
codon in translation, which can be incorporated into the DNA at a desired residue position 
of the target protein, “chemical handles” can be introduced on the surface of the protein. 
These functional handles then serve as sites of bioorthogonal reactivity. This strategy 
avoids the issue of multiple reaction partners on a single protein (which is typical when 
trying to conjugate on a cysteine/lysine residue), and allows the chemist to access new 
chemistries typically not available from the canonical 20 amino acids. Furthermore, 
compared to the strategies discussed above, this technique opens up the potential to exploit 
any protein that the chemist desires in a robust way. 
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I. UNNATURAL AMINO ACIDS 
 Within nature, there exist twenty canonical amino acids. These amino acids 
serve as building blocks for the plethora of proteins. Cellular proteins have numerous 
functions, as they catalyze the replication of our genetic information, provide structural 
support to our cells, and serve as defense mechanisms for our immune system, to name a 
few. The key to the proper function of these proteins is the arrangement of their amino acid 
sequence. By arranging the 20 amino acids in different combinations, proteins are able to 
capitalize on the unique structural and biochemical properties of each residue. The 
appropriate sequences allow for the protein to assemble properly, while also providing key 
catalytic functionality should it be required by the protein. Given the large number of 
functions proteins serve within an organism, as well as the myriad of ways in which they 
could be combined, it is reasonable to assume that evolution would have dictated the need 
for amino acids with diverse functional groups. However, a quick glance at the natural 20 
amino acids reveals only four main chemical functionalities: nonpolar, polar, acidic, and 
basic.3,9 
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Figure 2. There are 20 naturally occurring amino acids. Only five elements are represented in the canonical amino acids, 
as well as a very limited set of chemical functionality. Adapted from chemwiki.ucdavis.edu 
Advances in chemical biology have led to the development of UAAs that can be 
synthesized with novel biochemical properties not available in the 20 canonical amino 
acids. Such syntheses are relatively simple, as amino acids can be readily purchased with 
their carboxyl and amino ends masked with protecting groups. The result is a selectively 
reactive R-group that can be chemically modified. In particular, my research has focused 
on derivativizing the amino acid tyrosine (Tyr) that has a phenol functionality that can be 
activated by the addition of base. The deprotonated hydroxyl group can then undergo SN2 
reactions with molecules that posses good leaving groups. The result is a UAA that can 
serve as a starting point to introduce a myriad of novel biochemical functionality into 
proteins.  
13 
 
 
Figure 3. Unnatural amino acids allow chemists to access novel functionality and elements not present in the 20 
canonical amino acids. 
I.A. Incorporation of Unnatural Amino Acids 
 While the synthesis of UAAs is feasible, in order to capitalize on this technology 
it is necessary to be able to insert these UAAs into proteins of interest. Methods have been 
developed to site-specifically incorporate these UAAs into proteins via insertion in 
response to a TAG stop codon in the genome, giving researchers very precise control over 
the placement and number of these UAAs in a protein’s amino acid sequence.3 
Early methodology relied on incorporating UAAs in vitro. By utilizing cell-free 
protein assembly machinery, researchers were able to incorporate unnaturals into specific 
sites of the protein via a nonsense codon. The associated tRNA synthetase for this nonsense 
codon was then chemically aminoacylated with the UAA of interest. The result is a system 
that ensured the incorporation of the UAA into a single, predefine residue of the 
polypeptide. In particular, the amber suppressor codon (TAG) has been employed, as its 
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frequency in the Escherichia coli genome, the organism of choice for protein expressions, 
is relatively low. This ensures the incorporation of a single UAA into a single 
site.10,11While this approach allowed for the site-specific incorporation of a UAA into a 
protein’s primary sequence, the use of in vitro technology had serious limitations. Many 
proteins require the aid of additional proteins in vivo before they can acquire the correct 
conformation. As such, while this technique could impact the formation of small peptides, 
polypeptides could not be generated in a robust manner. This severely limited the 
biological applicability of UAAs. Furthermore, the synthesis of mutated proteins in vitro 
limits the use of this technology beyond biochemical studies. For example, novel methods 
of protein imaging in vivo could not be developed since this technique required cell-free 
machinery.  
An alternative strategy for UAA incorporation that allowed for the in vivo 
incorporation of UAAs involved the complete replacement of a particular amino acid in 
the organism’s proteome with a UAA. In this non-site specific UAA incorporation 
technique, the canonical amino acids methionine, leucine, isoleucine, phenylalanine, 
tryptophan, or proline are replaced by an amino acid that resembles of these amino acids 
in structure.12 Typically, cells transformed with a protein of interest are grown in complete 
media, pelleted, and the media removed prior to protein expression. Upon the induction of 
protein expression, the cells are resuspended in a new media that lacks one of these 
canonical amino acids. In place of the amino acid, an unnatural amino acid is included in 
the broth. By synthesizing amino acids that resemble the removed amino acid, scientists 
can trick the cell into incorporating their UAA in place of the canonical amino acid in the 
protein of interest. Tirrell and Finn demonstrated the utility of this approach by 
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synthesizing methionine analogs. In place of the thioether functionality, the group included 
azide and alkyne functionalities in their UAAs. As a result, the group was able to show that 
in place of methionine, E. coli induced to express a bacteriophage protein capsid would 
generate capsids labeled with either the azide or alkyne functionality in the residues that 
were originally methionine. While this approach also allows researchers to incorporate 
UAAs in a semi-site specific fashion, the frequency of UAA placment in a protein can be 
highly variable, due to the redundancy inherit in the 20 amino acid lexicon. The result can 
be complete dysfunction of the protein if the presence of multiple UAAs alters the protein’s 
structure too much. Additionally, this technique impacts the organism’s proteome, 
introducing the UAA in place of the canonical amino acid in every protein expressed. The 
result could be highly deleterious for the organism, which is not beneficial for in vivo 
applications.12   
Since these early in vitro studies, more recent work has focused on generating 
technology that would allow for the in vivo incorporation of UAAs. Additional challenges 
come into play when considering such techniques. First, as mentioned above, the 
incorporation of the UAA must be site specific, and it must occur only in the residue sites 
that have been previously determined by the researcher. Should the UAA be incorporated 
into additional non-specified sites, the result could be inactivation of the protein of interest, 
or subsequent death of the organism. Additionally, the tRNA machinery employed must 
act solely on the UAA of interest. By translating unnatural amino acid technonolgy towards 
in vivo incorporation, the added problem of having to deal with three elements arises. These 
elements include the UAA, the tRNA, and the aminoacyl-tRNA synthetase (aaRS) that is 
responsible with charging the tRNA with the UAA. In order for successful incorporation 
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to occur, the tRNA synthetase should only pair with the UAA and with the corresponding 
suppressor tRNA. This independence relative to the endogenous system is often referred 
to as orthogonality. Should such orthogonality not be maintained, endogenous amino acids 
could be incorporated into proteins in place of the UAA and vice versa. Finally, the UAA 
must be cell permeable and not cytotoxic in order to be incorporated.3,13  
 
Figure 4. Mechanism for genetic incorporation of unnatural amino acids. An orthogonal synthetase must be 
introduced that does not cross-react with any natural tRNA or amino acid. This is coupled with a new tRNA that 
harbors an anticodon for the TAG codon. When the ribosome encounters the TAG codon, a new amino acid is 
incorporated, rather than the discontinuation of translation. Adapted from Chem. Biol.  2009 16, 323-336. 
Early studies with E. coli models attempted to evolve an endogenous tRNA 
synthetase/tRNA pair that was orthogonal to a UAA of interest utilizing E. coli’s 
translational machinery. However, such tactics were wrought with misaminoacylation, and 
subsequently terminated.14 Instead, researchers focused on examining the protein 
translation machinery of other organisms, which would not interact with the endogenous 
aaRS/tRNA pairs but still allow efficient incorporation of the UAA. In vitro studies found 
that a tyrosine aaRS/tRNA pair from the archaea M. jannaschii was the first of such pairs 
used to successfully incorporate a UAA in an E. coli model.15 
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With acceptable aaRS/tRNA machinery in hand, researchers next focused on a 
means to alter the specificity of the pair to recognize different UAAs. This was done 
through a double-sieve selection method. First, a library of t-RNA synthetases was 
constructed based off the aaRS of M. jannaschii. Within this library, five to six residues 
within the binding site of the aaRS were genetically mutated to be one of the 20 amino 
acids, generating a library size on the order of 106 to 107 mutant aaRS. This library size is 
still viable for conventional double transformation procedures.  Next, the library underwent 
a positive selection. In this step, E. coli were transformed with the library of mutated 
synthetases and an enzyme encoding for a mutated-chloramphenicol degrading enzyme 
that contained an early TAG residue. Following double-transformation, the transformed 
cells were grown on a plate in the presence of a novel UAA and chloramphenicol. Survival 
implies the organism was able to use the foreign aaRS machinery to charge the suppressor 
tRNA and thus produce a functional chloramphenicol degrading enzyme.16 However, 
suppression does not guarantee that the aaRS charged the suppressor TAG using the UAA. 
As such, those cells that grow were then scraped off the plate and underwent a plasmid 
extraction. Following isolation on gel-electrophoresis, the sieved plasmid library is then 
subjected to a negative selection. In the negative selection round the toxic barnase gene is 
used. Barnase is a bacterial ribonuclease, and will degrade the cell’s RNA, preventing 
protein synthesis and leading to cell death. The gene was mutated to harbor three stop 
codons, and grown in the absence of unnatural amino acid. If the organism can use the 
exogenous aaRS/tRNA pair to charge endogenous amino acids and suppress the three stop 
codons, it will produce the barnase protein and die.16 Thus, the end of this two round 
procedure selected for organisms that possessed an aaRS/tRNA machinery that could 
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selectively incorporate the UAA to some degree. By iterating this process for multiple 
rounds with the UAA of interest, it was possible to evolve an aaRS/tRNA pair that works 
selectively for the UAA of interest. This is the evolution procedure used today.  
 
Figure 5. General scheme for the selection of an aminoacyl-tRNA synthetase that recognizes and incorporates a 
specific unnatural amino acid. 
II. BIOORTHOGONAL AND CLICK CHEMISTRIES 
 A growing area of interest in chemical biology is the ability to perform chemistry, 
particularly conjugation reactions, within living systems. In order for such chemistry to be 
feasible though, certain conditions must be met by the chemical reaction employed. Most 
importantly, the chemistry must not interfere with biological processes. That is, the reaction 
must be completely chemoselective, as well as rely on reactivity absent from endogenous 
biological chemical functionalities. Furthermore, the reaction must proceed at relatively 
rapid rates under physiological conditions (typically at 37°C and ~pH 7) as well as being 
inert to the myriad of functionalities encountered in biological systems.17  
 Should the conditions above be met, the chemistry is then deemed bioorthogonal. 
Bioorthogonality implies the reaction is capable of being performed in a biological system 
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in a selective manner without interfering with the already ongoing physiological processes. 
However, when considering the numerous functionalities found within living systems, as 
well as the limitations of concentrations and temperatures, the task of identifying 
bioorthogonal chemistries seems daunting.  
II. A. Maleimide-Thiol Chemistry 
 One of perhaps the earliest attempts at performing chemical reactions in a living 
organism was the conjugation reaction between a thiol and a maleimide.18,19 The technique 
has become a common approach for the labeling of reactive thiol groups in proteins, 
typically in the form of cysteine residues. In this reaction, the thiol acts as a nucleophile, 
adding across the double bond of maleimide to form a thioether. Furthermore, the reaction 
demonstrates a selectivity for thiols versus amines (a potential confounder), as the reaction 
with amines can only be accessed at higher pH ranges. Finally, hydrolysis of the maleimide 
substrate to an unreactive product is minimized at pH ranges below 8, well within the limits 
of a typical cellular environment.18 
Scheme 1. General Reaction for Addition of a Thiol across a Maleimide Double Bond 
 
 While the reactions between maleimides and thiols represent chemistry that can be 
performed in a cellular context, the chemistry is not truly bioorthogonal due to the presence 
of naturally occurring thiol groups in proteins. Current uses of the reaction involve labeling 
thiol-containing proteins with either a maleimide-derivatized biotin group (to increase 
molecular weight for SDS-PAGE isolation or for streptavidin purification) or a maleimide-
containing fluorescent probe. That being said, the maleimide functionality could be 
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integrated into a protein via UAA-technology, allowing for novel means of protein 
coupling with proteins containing reactive thiol groups or new labeling methods utilizing 
thiol-containing dyes.  
II. B. Cu-1,3-dipolar Cycloaddition or Cu(I) “Click” Chemistry 
Click chemistry, a subset of reactions that can proceed to completion in relatively 
mild conditions to produce a single product with minimal to no side reactions, has emerged 
as a means for performing bioorthogonal chemistry. In particular, the [3+2] cycloaddition 
of azides and alkynes, termed a Huisgen-1,3-dipolar cycloaddition, has flourished as a 
means to tackle the complexity of bioorthoganlitity.20 Not only do these reactions produce 
a stable, covalent triazole moiety, thus ensuring efficient and stable conjugation between 
the two functionalities in vivo where bonds may readily decompose, but the azide and 
alkyne functionalities are also not found in biological systems. Furthermore, the two 
molecules react selectively with each other, thus side reactions with other biological 
molecules is not a concern. Based on these facts, the 1,3-dipolar cycloaddition using azides 
and alkynes is an optimal chemistry for the development of bioconjugation reactions. 
However, the initial reaction reported in the early 20th century required temperatures 
upwards of 98°C, well above the temperature range of physiological viability.20  
 The viability of this chemistry was restored when the Sharpless and Meldal groups 
concurrently, yet separately, developed a copper(I) catalyzed variant of the 
cycloaddition.21,22 Reduction of copper(II) to copper(I) in the presence of a terminal alkyne 
allows for the formation of an activated copper acetylide intermediate, which has an 
increased reactivity with azides to form the traizole ring product. This copper-catalyzed 
azide-alkyne 1,3-dipolar cycloaddition (CuAAC) exhibited an increased reaction rate of 
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seven orders of magnitude, as well as being capable of reacting at room temperature and 
even 4°C.23 The fact that the reaction can be made even more favorable by the addition of 
tetradentate ligands, such as tris[(1-benzyl-1H-1,2,3-trizol-4-yl)methyl]amine (TBTA), 
that help stabilize the copper(I) catalyst resulted in this chemistry rising to the forefront of 
bioconjugation reactions.24 
Scheme 2. General Reaction Scheme for the Cu(I)-1,3-Dipolar Cycloaddition, or the Copper “Click” 
 
 While the CuAAC reaction afforded desirable temperature ranges and reaction 
rates, it possessed a single hindrance to its use in biological systems. The reaction’s 
dependence on copper was ultimately its greatest flaw, as copper is cytotoxic to most 
organisms. Bacterial cells have been shown to halt cell division following exposure to 100 
µM CuBr, and mammalian cells can only endure very low concentration of copper (below 
500 µM) for 1 hour.17 As such, the Bertozzi group sought to develop a copper free variant 
that may proceed with similar favorability by capitalizing on ring strain. In particular, 
cyclooctyne, the smallest ring that can contain a triple bond, was used to activate the alkyne 
towards the cycloaddition via strain. The result was a cycloaddition, however, the reaction 
proceeded at rates considerably slower than CuAAC.25 By addition of electron 
withdrawing fluorines, the Bertozzi lab was able to generate a difluoronated cyclooctyne 
(termed DIFO) capable of undergoing at copper free click reaction at rates comparable to 
CuAAC. Thus, the cycloocctyne reagent is nontoxic and can be derivitized to include 
additional functionality, such as conjugated fluorescent moieties.26  
22 
 
Scheme 3. Comparison between Cu “Click” and Strained Octyne [3+2] Cycloaddition17 
 
 CuAAC and strain promoted click chemistries (SPAAC) both serve as useful 
reactions for the bioconjugation of proteins bearing UAAs with other molecules. Because 
the placement of UAAs within a protein can be site-specifically controlled, UAAs can be 
inserted into proteins in unique residues that minimize changes to the protein’s folding 
while allowing for maximal exposure of the UAA. These surface exposed residue sites 
allow for UAAs to serve as unique biochemical handles for the targeted promotion of these 
bioconjugation reactions. If UAAs can be synthesized with azide or alkyne functionality, 
they could be correspondingly clicked to another molecule bearing the appropriate cognate 
handle. Such a strategy would allow for the directed control of bioorthogonal chemistry 
towards proteins of interest. 
 Indeed, both CuAAC and SPAAC have already begun to receive attention as novel 
methodologies to probe biological systems. Research on intracellular pathogens is often 
complicated due to the difficulty of probing the pathogen in their endosomal environment. 
Methods such as antibody labeling are complicated by the need to pass through multiple 
membrane structures. As such, Siegrist et al. demonstrated that UAA analogs of D-alanine, 
which harbor an alkyne functional group, can be used to probe peptidoglycan dynamics of 
intracellular bacterial pathogens in vivo, a technique that was not previously accessible 
using more traditional antibody labeling approaches.27 In particular, the authors 
demonstrated that the incorporation of the alkyne or azide derivitized D-alanine UAAs 
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allowed the researchers to perform CuAAC reactions using the orthogonal probe on a 
fluorescent dye. Because the D-alanine analogs are used exclusively by bacteria in the 
synthesis of their peptidoglycan layer, the researchers were able to label intracellular 
pathogens, such as Listeria monocytogenes, in an in vivo model and then observe 
peptidoglycan dynamics in real time. 
 Beyond UAAs, CuAAC chemistry can also be extended to other biomolecules, like 
sugars. Mycobacterium tuberculosis, the causative agent of tuberculosis, uses the non-
mammalian disaccharide, trehalose, as a precursor for essential cell wall glycolipids, as 
well as other metabolites.28 However, not many strategies currently exist to visualize the 
metabolism of this sugar essential to M. tuberculosis. As such, the Bertozzi group 
generated an azide-trehalose derivative, which they could subsequently ligate to alkyne-
functionalized probes via CuAAC chemistry. This allowed the group to explore the fate of 
the trehalose analogs, generating novel techniques for the investigation of the 
mycobacterial trehalome and how this sugar is incorporated into the cell membrane. 
II. C. Glaser-Hay Coupling Chemistry 
 As demonstrated by the click chemistries, it is apparent that reactions involving 
terminal alkynes are advantageous for use in biological systems due to the relative absence 
of triple bonds within these systems. The Glaser-Hay coupling is a reaction that involves 
conjugating two terminal alkynes via a copper catalyst to afford a conjoined diyne 
product29,30 Salts of copper(I) are typically used as the catalyst, and it has been proposed 
that the copper(I) complexes with the terminal alkyne, activating the functionality towards 
the formation of a carbon-carbon bond with another terminal alkyne.31,32  
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Scheme 4. General Reaction of the Glaser-Hay Coupling 
 
 The coupling of terminal alkynes was first described by Carl Glaser in 1869.29 
However, the initial reaction was not suited for biological settings. Glaser’s initial reaction, 
however, involved an explosive copper(I)-phenylacetylide catalyst that required tedious 
isolation following the reaction.29 Then, in 1962, Allan Hay published results using the 
bidentate ligand N,N,N’,N’-tetramethyletheylene diamine (TMEDA) in conjunction with 
the copper catalyst. This methodology improved reaction times, reduced temperature 
requirements, and reduced the amount of copper necessary to allow the reaction to 
proceed.30 By conjugating the Cu(I) catalyst, it is proposed that the bidentate ligand 
TMEDA stabilizes the Cu(I) species, opening up the complex to favor addition of the 
activated alkyne species to one end of the copper species.31,32 The Glaser-Hay reaction 
today, in which a Cu(I) salt in the presence of TMEDA in an organic solvent is added to 
two terminal alkynes, allows for the rapid and facile synthesis of conjugated diynes. 
Furthermore, recent work has demonstrated the reaction can proceed in good yield under 
biological temperatures (4℃ to 37℃), and has enhanced reaction rates.33 While little work 
has been done to take advantage of these unique features of this chemistry, these 
characteristics make the Glaser-Hay coupling ideal for the utilization of the bioorthogonal 
alkyne moiety for bioconjugation applications.  
III. CONCLUSION 
 UAA-mutagenesis technology allows the researcher to create site-specific 
functional “handles” on proteins of interest. Herein we propose applying UAA-
25 
 
mutagenesis for the development of novel biological probes and immobilization 
techniques. By combining this technique with bioorthogonal chemistries, we hope to 
manipulate biological systems and proteins in new ways that can further advance our 
society and understanding of the world.  
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CHAPTER 2: DEVELOPMENT OF UNNATURAL AMINO ACID 
TECHNOLOGY FOR BIOCONJUGATION APPLICATIONS 
 
 
I. INTRODUCTION 
 Green fluorescent protein (GFP) is a 26kDa protein isolated from jellyfish.34 
Unique to GFP’s photochemical properties is a tripeptide chromophore composed of 
Ser65-Tyr66-Gly67.34 The protein contains a β-barrel structure, as well as an internal α-
helix within the barrel core. Within this internal α-helix is Ser65-Tyr66-Gly67. When the 
protein has folded correctly, these three amino acids are in the correct conformation to 
undergo a series of cyclization, dehydration, and oxidation reactions, which result in the 
formation of the GFP chromophore. This chromophore is further stabilized by the 
hydrophobic interior of the protein, allowing the protein to fluoresce when it is struck by 
the appropriate wavelength of light.  
By inserting TAG mutations into the GFP DNA, it is possible to generate GFP 
mutants with UAAs at predefined residue positions.35 These residues can be surface 
exposed, such as 3, 133, and 151, or they can even be part of the chromophore itself, such 
as residue 66. The placement of the UAA grants GFP with either new surface-exposed 
chemical functionality or new emission spectra. Furthermore, the unique structural 
properties that allow GFP to fluoresce also make GFP an ideal reporter protein for work 
involving UAAs. The successful suppression of the TAG stop codon via the incorporation 
of a UAA will generate a functional and fluorescent mutant GFP. However, if a UAA is 
not incorporated, for example, due to poor UAA-recognition by the orthogonal aaRS 
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machinery, then the protein translation will terminate early and will not fold correctly. 
Because of the stringent folding-conditions required for the formation of the GFP 
fluorophore, this improper folding results in lack of fluorescence. Thus, the observable 
fluorescence of GFP makes it an ideal reporter protein for this work involving GFP. 
Recently, our lab has shown that UAA-based mutagenesis allows for the site-
specific immobilization of proteins, GFP specifically, on a sepharose resin.35 This 
technology hinges on the use of an azide-derivatized UAA which was incorporated on the 
surface of green fluorescent protein (GFP) via TAG suppression. By performing a Cu(I)-
catalyzed 1,3-dipolar cycloaddition between an azide and an  alkyne, the azide-derivatized 
GFP reacts with the alkyne-derivatized resin, forming a covalent triazole ring between the 
two in a pre-defined position (see Figure 1). Furthermore, immobilization did not impede 
protein fluorescence. Rather, we showed that immobilization actually aided in the 
maintenance of protein stability even in the presence of harsh organic solvents. Therefore, 
this technology confers protein-based technologies a wider range of use in harsh organic 
solvents and extreme environments. While this demonstrated a proof-of-concept, further 
research is required to better understand immobilization conditions and apply the UAA 
technology further. 
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Figure 6. UAA residue context dependence on immobilization. (A) Various GFP pAzF mutants were expressed with the 
UAA at different positions (highlighted in blue), adapted from PDB: 1EMA.(39) (B) Fluorescence data demonstrating 
maximal immobilization with the pAzF-GFP-151 mutant, suggesting some importance of UAA context within the protein 
for the immobilization. All error bars represent standard deviations from three independent experiments.35 
 
II. RESULTS AND DISCUSSION 
Initial investigations explored how UAAs could be utilized to optimize protein 
immobilization, and thereby generate novel protein-based technologies in the future. Two 
key research aims were assessed to optimize our immobilization technique. First, new 
bioorthogonal chemical reactions to immobilize proteins were investigated. In our previous 
reports, only the Cu(I)-catalyzed 1,3-dipolar cycloaddition was probed as a viable reaction 
to immobilize GFP; however, there currently exist a wide-range of bioorthogonal reactions 
which rely on less harsh catalysts and enhanced rates. In particular, we were interested in 
examining the Glaser-Hay coupling reaction between terminal alkynes as a prime candidate 
for conjugation with biological agents. This reaction is advantageous due to its rapid 
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reaction rates (4 hours), low temperature requirements (anywhere between 37-4 degrees 
Celsius), and milder conditions (CuI and TMEDA).36  
Additionally, our previous studies immobilizing protein demonstrated that the 
UAA residue location on the protein dictated its resin immobilization efficiency.35 Thus, 
the spatial configuration of the UAA handle is vital for its reactivity with its conjugation 
partner. While it is possible to alter where the UAA can be incorporated, this requires 
extensive genetic manipulation. An alternative approach is to simply vary the distance of 
the UAA reactive group from the protein’s surface. By extending the distance from the 
protein, the handle is less hindered by the protein’s steric bulk, which may increase its 
propensity to react with its orthogonal partner. Thus, the research also aimed to determine 
the ideal distance of the functional handle from the protein for efficient reactivity.  
In order to probe novel bioorthogonal reactions utilizing UAA technology, a variety 
of UAAs with new functional groups were synthesized and designed with variable tether 
lengths to separate the reactive species from the bulk of the protein. These groups included 
an azide, an alkyne, and a bromide respectively, all of which extended from a derivatized 
tyrosine (see Scheme 1). These functionalities afford access to the Cu(I)-catalyzed 1,3-
dipolar cycloaddition, the Glaser-Hay coupling, and a nucleophilic substitution 
respectively.  
II.A. Synthesis of Unnatural Amino Acids 
To optimize the immobilization process, UAAs were synthesized with various 
numbers of methylene units extending from a tyrosine precursor. Derivatives containing 2, 
3, and 4 methylenes of the azide, alkyne, and bromide functionalities previously mentioned 
are readily accessible via an SN2 reaction (Scheme 1). 
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Scheme 5. Final Overall Reaction Scheme for the Synthesis of UAAs 
 
Synthesis of the nine UAAs began from a common N-Boc/OMe protected tyrosine 
precursor. The goal was to synthesize a bromotyrosine derivative via a substitution reaction 
with either dibromoethane, dibromopropane, or dibromobutane, all of which are 
commercially available. These bromo-tyrosines would then have alkyl chains of varying 
lengths, and possess a bromine that could serve as a good leaving group in future reactions. 
Then, reaction with either an azide or alkynyl nucleophile would yield novel reactivity to 
the tyrosine derivatives. However, synthesis of the bromo-tyrosine series proved more 
difficult than initially anticipated. 
Initial reactions between the protected tyrosine and the dibromobutane in 
dimethylformamide (DMF) yielded the desired tyrosine derivative 3. However, reactions 
involving the dibromopropane and dibromoethane in DMF did not proceed as expected 
towards the desired tyrosine derivatives 2 and 1 respectively. Instead, starting material or 
the alkene tyrosine derivative, the product of an elimination reaction, was obtained for both 
reactions.  
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Scheme 6. Elimination Byproduct of the Bromotyrosine Synthesis 
 
Initially, the concern was that the DMF was not dry, and the presence of water in 
the solvent may have led to elimination of the bromide. However, switching to dry solvent 
systems did not improve the reaction, nor did it reduce the amount of elimination product 
obtained. To optimize the reactions, we attempted adding a catalytic amount of potassium 
iodide to both the dibromopropane and dibromoethane reactions. The iodide can serve as 
a catalyst in this nucleophilic substitution, replacing the bromine with iodine, a better 
leaving group, which should facilitate the SN2 addition by the hydroxyl group of tyrosine. 
However, only starting material was recovered from these reactions, even when reaction 
times and temperatures were varied. Ultimately, a literature search revealed a similar 
compound had been successfully prepared using acetone as the solvent system.37,38 Thus, 
all three reactions were attempted in acetone, with greater success. All three bromotrysoine 
derivatives were successfully synthesized using acetone as the solvent system in the 
presence of base and potassium iodide as a catalyst. We hypothesize that the additional 
polar amine functionality in the DMF allowed for increased solvent-mediated stability of 
the free bromine via dipole-dipole interactions following an elimination reaction. Thus, 
DMF aided in the formation of the eliminated product. Furthermore, electronics are clearly 
involved, as the shorter the alkyl chain became, the closer in proximity the large, 
electronegative bromine groups were, increasing the propensity to eliminate. This was 
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observed by a higher rate of elimination product using dibromoethane when compared to 
dibromopropane. The use of acetone, a less polar solvent, decreases the solvent-mediated 
dipole-dipole interactions with the free bromine, and thus disfavors the elimination 
reaction. This was observed as the bromotryosine derivatives were able to be successfully 
synthesized under these modified conditions. 
Once the bromotyrosine compounds 1 to 3 had been synthesized, they were then 
divided and reacted with either sodium azide or propargyl alcohol. Reaction with sodium 
azide in DMF resulted in a nucleophilic substitution reaction between the azide and the 
bromotryosine, affording the azidotyrosine derivatives 4 through 6 following purification 
and NMR confirmation. The other set was reacted with propargyl alcohol in DMF in order 
to perform a nucleophilic substitution between the hydroxyl group and the bromotyrosine, 
resulting in the formation of the alkynyltyrosine product. 
The alkyne-derivitized tyrosine series was not successfully synthesized under these 
conditions, and instead yielded either the previously described elimination product or the 
starting material.  
Scheme 7. Synthesis of Alkynyltyrosine Derivatives Using Propargyl Alcohol 
Initially, potassium tert-butoxide (pKa ~17) was used as the activating base in the reaction. 
We hypothesized that the propargyl alcohol (pKa ~13.6) may not be fully deprotonated 
under these conditions, perhaps reducing the overall yield of the reaction.1  As such, a small 
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amount of sodium hydroxide was used as the activating base with little success. Ultimately, 
due to the inability to obtain derivatized tyrosine product, an alternative synthesis strategy 
was adopted. Reaction of 4-bromo-1-butyne and 5-bromo-1-pentyne with protected 
tyrosine in acetone with a catalytic amount of potassium iodide was allowed to progress 
overnight. Following column chromatography, the desired alkyne products 7 and 8 were 
obtained, with the proper length alkyl chains (either 3 or 2 methyl) for proper comparison 
to the azido- and bromo- derivatives of similar lengths. In addition, 6-bromo-1-hexyne 
could be readily synthesized by reacting 6-hydroxy-1-hexyne with phosphorus (III) 
bromide, followed by immediate reaction with the protected tyrosine in acetone. Again, 
following column chromatography the desired compound 9 was isolated.  
Scheme 8. Synthesis of 6-Bromo-1-hexyne 
 
The synthesis described above results in the derivatized tyrosines still harboring 
protecting groups. To prevent reactivity of the amino group of the amino acid, an acid labile 
tert-butyloxy (Boc) group was employed. Additionally, to protect the carboxylic acid 
functional group of the amino acid backbone, a base labile methyl ester was used. 
Following successive stirring in 1M lithium hydroxide to remove the methyl ester and 2% 
TFA in DCM to remove the Boc group, the deprotected UAAs were concentrated under 
vacuum and analyzed by  1H- and 13C NMR. Table 1 summarizes the overall deprotected 
UAA yields for this general reaction protocol.  
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Table 1. Overall Yields For the Synthesis of all Deprotected UAAs 
 
II.B. Incorporation of Unnatural Amino Acids 
Following the Schultz methodology for the incorporation of UAAs (see Chapter 1), 
the deprotected unnatural amino acids were then incorporated into green fluorescent 
protein (GFP) on the surface exposed residue 151, using transformed E. coli. GFP, in this 
case, was an ideal reporter protein, as successful incorporation of the UAAs could be 
monitored by fluorescence. Because the incorporation of UAAs is based on the suppression 
of a TAG (amber stop codon) mutation in the DNA encoding the protein, E. coli cultured 
in the absence of the UAA will terminate protein translation early, resulting in an 
incomplete protein and an absence of fluorescence (see Figure 7). 
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Figure 7. Successful suppression of the TAG stop codon results in translation of Green Fluorescent Protein (GFP), and the 
presence of fluorescence. In the absence of a UAA, GFP translation is terminated  early, resulting in a protein that cannot 
fold correctly to produce fluorescence.  
 Furthermore, because residue 151 in the wt GFP is a tyrosine residue, we 
hypothesized that addition of tyrosine-derivatives 10 to 18 would not disrupt the overall 
folding of the protein. All UAAs were successfully incorporated into GFP using the pCNF 
synthetase. This synthetase was originally evolved for the para-cyanophenylalanine UAA, 
however, the double-sieve selection methodology discussed in chapter 1 was not pursued 
as rigorously. As a result, recent work has demonstrated that the pCNF synthetase is a 
highly promiscuous synthetase.39 Recent work has demonstrated that this synthetase is 
capable of charging at least twenty UAAs with a tyrosine or phenylalanine core and with 
variable functional groups. Based on this work, it was hypothesized that this synthetase 
could recognize and charge compounds 10 to 18 to the TAG-tRNA for incorporation into 
GFP, obviating the need to do synthetase evolutions for each individual compound. 
Because the pCNF synthetase was evolved to recognize pCNF, it was hypothesized 
that the p2AzY-, p3AzY-, and p4AzY-UAA series would be most easily incorporated due 
to the structural similarity between the cyano group and azide group in size and 
polarizability. This result was observed, with the p2AzY producing a larger quantity of 
mutant-GFP, and the p4AzY producing the lowest quantity of mutant-GFP within the azido 
series. These qualitative observations make sense based on the evolution of the synthetase. 
Because the synthetase was evolved for a UAA that contained a cyano in the para position 
36 
 
on the ring of phenylalanine, it makes sense that the increased tether distance may have 
more difficulty fitting into the binding pocket relative to smaller derivatives. The steric 
bulk of p4AzY may not allow it to fit as well into the binding pocket of the pCNF-
synthetase, preventing the UAA from being charged to the TAG-tRNA, and leading to 
early termination of GFP translation (and thus a decrease in observed fluorescence 
following protein purification). Thus, a tradeoff may exist between the advantages of 
distancing the functional group from the core of the protein and the reduced protein yields 
of these same compounds. The bromotyrosine UAA series had the next highest protein 
yields, and followed a similar trend. The alkynyltyrosine UAA series had the lowest protein 
yields, with very little protein obtained throughout the series of derivatives. The enhanced 
yields of the bromo-series over the alkynyl-series is possibly due to similarity in size and 
shape between the azide groups and the bromo groups of the tyrosine derivatives, whereas 
the alkyne functionality was unable to fit as easily in the synthetase binding pocket. All 
proteins were purified via a Ni-NTA affinity chromatography due to the presence of a 6X 
histidine tag, and eluted in a solution with increased imidazole concentrations.  
II.C. Bioorthogonal Chemistry Experiments 
With the UAA-mutated GFP in hand, it was then possible to examine the 
capabilities of the various functional handles for bioorthogonal reactivity. Initial studies 
involved the p2AzY-, p3AzY-, p4AzY-GFP series. To test for bioorthogonal reactivity, we 
exposed the azido-GFPs to a fluorescent dye containing an alkynyl functional group 
(Alexafluor 488). We expected the formation of a triazole ring between the dye and the 
azido-GFP in the presence of the Cu(I)-1,3-dipolar cycloaddition (Copper “click”) 
conditions.  
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Scheme 9. General Reaction for the Cu(I)-1,3-Dipolar Cycloaddition (or Copper(I) “Click”) 
 
Thus, when the GFP was denatured, a fluorescent band due to the presence of the 
conjugated dye should still appear at the appropriate molecular weight band for GFP (~26 
kDa) via SDS-PAGE in only those proteins exposed to the copper click catalyst (CuSO4). 
Furthermore, because the dye is small, it should not impact the migration of the GFP 
protein on the gel. 
Initial optimization trials for the copper “click” involved reactions between p-
azidophenylalanine (pAzF), a commercially available UAA with no tether group between 
the aromatic ring and the azide moiety, and the fluorescent dye in the copper click 
conditions based on literature conditions were not successful, as indicated by the absence 
of fluorescence at 26 kDa on SDS-PAGE.40,41 
Scheme 10. Initial Click Trials Using pAzF-GFP and Alexafluor 488 
 
We next attempted varying the CuSO4 concentrations (either 1M, 50mM, or 1mM) 
to no avail. Furthermore, we attempted using either sodium ascorbate or tris(2-
carboxyethyl)phosphine (TCEP) as reducing agents, at various concentrations as well. This 
did not produce positive results either. Finally, based on a literature precedence a chelating 
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ligand to help increase the stability and reactivity of the copper(I) species was added. 
Tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine (TBTA), which is a tetradentate ligand 
was selected to aid in the reaction.40,41 Initial click attempts in the presence of this ligand 
revealed promising results, however, none were replicable. Ultimately, it was realized that 
purification of proteins required transferring the protein from the imidazole buffer to 
phosphate buffer solution (PBS).41 Thus, solvent exchange of the pAzF-GFP to PBS via a 
concentrator column resulted in a successful click reaction between the pAzF-GFP and the 
alkyne-dye in the presence of CuSO4 (50 mM), TCEP (50 mM), and TBTA (20 mM). We 
hypothesize that the presence of imidazole in the elution buffer must have coordinated with 
the copper (I) species, preventing it from coordinating with the alkyne functional group 
and catalyzing the formation of the triazole ring with the azido-handle of the mutant-GFP.  
Figure 8 demonstrates the successful copper click reaction between p2AzY-, 
P3AzY-, and p4AzY-GFP and the alkyne-derivitized Alexafluor 488. All mutant proteins 
were subjected to an experimental trial in the presence of the copper click catalyst system 
(CuSO4, TCEP, TBTA) and a control in presence of the alkyne fluorophore but in the 
absence of the copper click catalyst system. This control allowed us to rule out non-specific 
interactions as the mechanism for binding between the dye and the mutant-GFP. After 
running overnight at 4℃, the proteins were denatured at 98℃ for 15 mins and then analyzed 
via SDS-PAGE. As indicated by the top gel, all protein expressions using the azido-UAA 
series were successful, as indicated by the presence of a band at 26 kDa, the molecular 
weight of GFP. Furthermore, the relative widths of the band confirm the visual 
observations discussed above: UAAs p2AzY and p3AzY had higher GFP yields than the 
bulkier p4AzY. The bottom lane demonstrates the successful bioconjugation between the 
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azido-GFPs and the alkyne-derivitized Alexafluor 488. Because the GFP is denatured, only 
the fluorophore will fluoresce, with fluorescence at a molecular weight of 26 kDa 
indicating that the fluorophore is conjugated to the GFP. Furthermore, no coupling was 
observed in the absence of the copper catalyst system, even in the presence of the 
fluorophore, indicating that bioorthogonal copper click chemistry is responsible for the 
conjugation between the fluorophore and the dye.  
 
Figure 8. Expression of GFP-151 mutants with azide tethered tyrosine UAAs. The top gel indicates the successful 
incorporation of all three azides in the series as an appropriate band is observed for GFP at ~26 kDa when stained with 
coomassie blue. Each azido-GFP mutant also was able to undergo a successful bioconjugation with an AlexaFluor-488 
alkyne. No coupling was observed in the absence of copper catalyst despite the inclusion of the fluorophore alkyne. This 
is apparent when observing fluorescent bands in the bottom gel. 
Interestingly, the p3AzY handle appears to have the best conjugation efficiency, 
compared to the more sterically hindered p2AzY and the more flexible p4AzY handles. 
Next, we attempted to perform the Glaser-Hay reaction between the p2yneY-, 
p3yneY-, p4yneY-GFP, and the alkyne-fluorescent dye.  
Scheme 11. General Schema for the Glaser-Hay Coupling 
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Figure 9 indicates that our initial attempt using CuI (50mM) and 
tetramethylethylenediamine (TMEDA, 50 mM) as a catalyst system was successful. All 
mutant proteins were subjected to an experimental trial in the presence of the Glaser-Hay 
catalyst system (CuI, TMEDA) and a control in presence of the alkyne fluorophore but in 
the absence of catalyst system. This control allowed us to rule out non-specific interactions 
as the mechanism for binding between the dye and the mutant-GFP. After running 
overnight at 4℃, the proteins were denatured at 98℃ for 15 mins and then analyzed via 
SDS-PAGE. As indicated by the top gel, all protein expressions using the alkynyl-UAA 
series were successful, as indicated by the presence of a band at 26 kDa, the molecular 
weight of GFP. The bottom lane demonstrates the successful bioconjugation between the 
alkyne-GFPs and the alkyne-derivitized Alexafluor 488. Because the GFP is denatured, 
only the fluorophore will fluoresce, with fluorescence at a molecular weight of 26 kDa 
indicating that the fluorophore is conjugated to the GFP. Furthermore, no coupling was 
observed in the absence of the Glaser-Hay catalyst system, even in the presence of the 
fluorophore, indicating that bioorthogonal Glaser-Hay chemistry is responsible for the 
conjugation between the fluorophore and the dye. Even more interesting is the presence of 
a slight band at ~52 kDa in only the experimental samples (Lanes 2, 4, and 6), which 
suggests that a homodimerization between alkynyl-GFPs in the presence of the Glaser-Hay 
system occurred. Even more interesting is the relative intensities of this band, with the 
p4yneY-GFP have the darkest band, and thus the most homodimerization, and the p2yneY-
GFP having the lightest band, and thus the least homodimerization. This would be 
expected, as the increased distance off of the protein afforded by p4yneY UAA would 
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reduce the steric hindrance of the protein, potentially increasing the propensity of this 
functional handle to react.  
 
Figure 9. Expression of GFP-151 mutants with alkyne tethered tyrosine UAAs. The top gel indicates the successful 
incorporation of all three alkynes in the series as an appropriate band is observed for GFP at ~26 kDa when stained with 
coomassie blue. Each alkyne-GFP mutant also was able to undergo a successful bioconjugation with an AlexaFluor-488 
alkyne. No coupling was observed in the absence of copper catalyst despite the inclusion of the fluorophore alkyne. This 
is apparent when observing fluorescent bands in the bottom gel. In addition, the presence of bands at ~52 kDa suggests 
homodimerization in the presence of copper catalyst as the alkyne-GFP mutants conjugate with themselves. 
The final reaction we sought to perform on our mutant protein was a nucleophilic 
substitution between a nucleophilic dye and our bromo-mutated GFPs. Due to the presence 
of many nucleophilic functional groups within biological settings, this reaction is not truly 
bioorthogonal because cross-reactivity is likely. Nevertheless, we reasoned that successful 
nucleophilic substitution with a dye was an ideal means to demonstrate the successful 
incorporation of the bromo-UAAs and the generation of the p2BrY-, p3BrY-, p4BrY-
GFPs. Furthermore, we wanted the reaction to still have some biological contextualization.  
Glutathione (GSH) is a tripeptide composed of glutamine, cysteine, and glycine.1 
Thanks to the reactive nature of the cysteine’s thiol group, GSH readily undergoes 
substitution chemistry in vivo as a means to modulate protein oxidation states. In solution, 
GSH can exist in one of two forms: the reduced glutathione (GSH) form, in which the thiol 
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group is protonated, or in the oxidized dimeric form (GSSG), in which the cysteine residues 
form a disulfide bond. In vivo, the reversible exchange of glutathione between these two 
forms allows the tripeptide to modulate protein oxidation states. 
 
Figure 10. Glutathione (GSH) can exist in either a reduced or oxidized form, based on the oxidation state of the cysteine’s 
thiol group. Only the reduced form of GSH can undergo a nucleophilic substitution reaction with our bromo-GFP mutants. 
Thankfully, the Landino lab at William and Mary has already established a 
precedent for generating GSH-labeled dyes.42 By reacting fluorescein or dansyl dyes with 
the free amino end of GSH, the Landino group has been able to generate labeled-GSHs that 
are still capable of performing redox chemistry with proteins of interest. Thus, we reasoned 
that the dansyl-labeled glutathione (d-GSH, see Figure 5), would be an ideal label to 
undergo a nucleophilic substitution reaction with our bromo-GFP series. 
Scheme 12. General Reaction Schema for the Nucleophilic Substitution of Bromo-GFP by a Reactive Thiol Group 
 
We obtained d-GSH (~3 mM) from the Landino lab as a nucleophile in reaction 
with our bromo-GFP in PBS at 4℃ overnight. However, this reaction did not work. We 
hypothesized that the d-GSH could have oxidized, and thus no free thiol group was free to 
serve as nucleophile to displace the bromide. As a solution, we attempted the reaction, this 
time in the presence of 20mM imidizaole to serve as a mild base to help activate the thiol, 
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and 50 mM TCEP as a reducing agent to reduce any oxidized d-GSH. This reaction was 
performed at 4℃ overnight. However, the reaction results were inconclusive, as a weak 
fluorescence at the band associated with denatured GFP was observed, but it was also 
somewhat present in the wild-type control, as shown in Figure 3. We hypothesize that due 
to the lower affinity of the synthetase for the bromotyrosine UAAs, the GFP yield is 
considerably reduced. Furthermore, the d-GSH may have been oxidized due to improper 
handling, further reducing the amount of d-GSH that may have reacted. These two factors 
combined can lead to a considerably decreased yield of d-GSH-labeled GFP, which would 
increase our signal to noise ratio on the SDS-PAGE making detection difficult. Future 
studies will attempt this substitution again, this time with more concentrated p2BrY-, 
p3BrY-, and p4BrY-GFPs and a freshly prepared stock of d-GSH.  
 
Figure 11. Expression of GFP-151 mutants with bromo tethered tyrosine UAAs. The top gel indicates the successful 
incorporation of all three bromotyrosines in the series as an appropriate band is observed for GFP at ~26 kDa when 
stained with coomassie blue. The bromo-GFP mutants were able to undergo a nucleophilic substitution reaction with 
dansyl-labeled glutathione to varying degrees.  
II.D. Bioorthogonal Chemistry Applied Towards Protein Immobilization 
With successful bioorthogonal reaction conditions in hand, we next sought to apply 
the chemistry for immobilization purposes. As mentioned previously, the most robust and 
ideal mechanisms for protein immobilization involve covalent linkage. However, this 
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technique is often confounded by the potential for multiple reaction sites on a given protein, 
which could render proteins that are oriented incorrectly for their function. UAA 
mutagenesis allows for the development of a bioorthogonal handle in a predetermined 
site.43 This predefined functional group can then be exploited via bioorthogonal chemistries 
for the generation of a covalent linkage between the UAA-mutant protein and the solid 
support at a predefined site.35 This strategy prevents the complications of having multiple 
reaction sites as well as improperly oriented proteins, as the number and positions of UAAs 
can be controlled by the scientist. As such, we sought to apply UAA-based technologies to 
generate covalent linkages between UAA-mutated GFP and a solid support in a site-
specific manner.  
For reaction with the azido- and alkynyl-GFP mutants, an expoxy-activated 
sepharose resin was derivatized with propargyl alcohol in the presence of trimethylamine 
(TEA) by stirring overnight at room temperature.35 This afforded a resin with an alkyne 
functionality, which was confirmed via the successful coupling of the resin with the alkyne-
dye under Glaser-Hay coupling conditions.  
 
Figure 12. A. The reaction scheme for the formation of an alkyne derivatized resin. B. An alkyne containing dye was 
immobilized on the alkyne resin via the Glaser-Hay coupling, demonstrating that the reaction performed in A. was 
successful.  
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Next, we reacted the alkyne-derivatized resin to the various azido-tyrosine mutated 
GFPs under the previously established click conditions. We reasoned that by extending the 
tethering distance of the functional handle of the UAA, and thus the site of bioorothogonal 
reactivity, we could decrease steric hindrance due to the protein’s bulk and improve 
immobilization efficiency as measured by an increase in covalently-bound GFP on the 
resin. As such, the azidoethyl-, azidopropyl-, and azidobutyl-mutated GFPs were exposed 
to copper click conditions (50 mM CuSO4, 50 mM TCEP, and 20 mM TBTA) at fixed 
concentration of GFP (roughly 0.250 mg/mL). As a positive control, the p-
azidophenylalanine mutated GFP, which has no tether between the aromatic ring and the 
azide functional group, was also subjected to the same copper click conditions. Our lab has 
previously immobilized the p-azidophenylalaninie mutated GFP on the alkyne-
functionalized sepharose resin using similar conditions.35 As a negative control, wild type 
GFP, in which there is no azido-functional group present, was also subjected to the same 
copper click conditions. This control provided a means to rule out non-specific interactions 
as the reason for immobilization rather than the selective copper click reaction. Figure 13. 
demonstrates that our copper click-based immobilization strategy was effective. 
Interestingly, the tether distance did factor into the efficiency of the immobilization 
reaction, as increased distance from the protein did not necessarily lead to improved 
immobilization (as measured by relative fluorescence intensity on a microplate reader). 
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Figure 13. Expression of GFP-151 mutants with either an azide tethered tyrosine UAAs or a p-azidophenylalanine. a. 
The graph demonstrates the successful immobilization of GFP at a fixed concentration of 0.246mg/mL of protein. 
Fluorscence signal read at 528nm indicates that the n=2 GFP-151 azide tethered variant performed best for 
immobilization. b. The bottom image displays the immobilized resins as viewed on a 368nm plate reader. Overall, the 
tethered variants appeared to have a greater immobilization efficiency, suggesting improved access to the functional 
handle thanks to the greater distance from the protein.  
Next we sought to immobilize the alkyne-functionalized GFP on the same alkyne-
functionalized sepharose resin using the Glaser-Hay coupling conditions. However, this 
strategy did not prove as effective. Due to the reduced yields of the alkyl-tyrosine mutant 
GFP series, we could not obtain sufficient protein concentrations in order to obtain 
observable immobilization results. Current work is focusing on resynthesizing these alkyl-
tyrosine UAAs for larger protein expressions, which will hopefully yield greater quantities 
of protein for future immobilization studies. 
Current work is also attempting to generate an amine functionalized resin using the 
epoxy-activated sepharose resin and ethylenediamine. Once made, we plan on using the 
amine group of this resin as a nucleophile in the substitution reaction of the bromo-tyrosine 
mutated GFP series for immobilization of these mutant GFPs as well.    
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III. EXPERIMENTAL 
Synthesis of p-Bromo-ethyl-Boc-OMe-Tyrosine (1). A solution of Boc-Tyrosine-OMe 
(0.500 g, 1 eq, 1.693mmol) was created in acetone (5 mL) in a flame-dried vial. To this 
solution, potassium carbonate (0.702 g, 3 eq, 5.079 mmol) was added, followed by the 
addition of dibromoethane (292 μL, 2 eq, 3.383 mmol). The reaction stirred overnight at 
56℃. It was then cooled to room temperature, filtered into a roundbottom and the 
precipitate in the vial washed with ethyl acetate. The filtrate was then rotovapped. Colum 
chromatography (silica gel, gradient of 9:1 hexanes/ethyl acetate for 5 fractions followed 
by 7:1  hexanes/ethyl acetate for 10 fraction followed by 5:1 hexanes/ethyl acetate) 
afforded the desired product as a clear oil (36 mg, 0.089 mmol, 5.3% yield). 1H NMR (400 
MHz, CDCl3): δ 7.02 (d, J =8 Hz, 2H), 6.82 (d, J = 8 Hz, 2H), 4.96 (d, J = 8 Hz, 1H), 4.53 
(d, J= 8 Hz, 1H), 4.01 (t, J = 4 Hz, 2 H), 3.70 (s, 3 H), 3.51 (t, J = 8 Hz, 2 H), 2.94 (m, 2 
H), 1.41 (s, 9 H) 
Synthesis of p-Bromo-propyl-Boc-OMe-Tyrosine (2). A solution of Boc-Tyrosine-OMe 
(0.500 g, 1 eq, 1.693mmol) was created in acetone (5 mL) in a flame-dried vial. To this 
solution, potassium carbonate (0.702 g, 3 eq, 5.079 mmol) was added, followed by the 
addition of 1,3-dibromopropane (345 μL, 2 eq, 3.383 mmol). The reaction stirred overnight 
at 56℃. It was then cooled to room temperature, filtered into a roundbottom and the 
precipitate in the vial washed with ethyl acetate. The filtrate was then rotovapped. Colum 
chromatography (silica gel, gradient of 7:10 hexanes/ethyl acetate for 10 fractions followed 
by 5:1 hexanes ethyl acetate for 10 fractions) afforded the desired product as a clear oil (18 
mg, 0.283 mmol, 33.5% yield). 1H NMR (400 MHz, CD3OD): δ 6.99 (d, J = 8 Hz, 2 H), 
6.78 (d, J = 8 Hz, 2 H), 5.07 (d, J = 4 Hz, 1 H), 4.59 (d, J = 4 Hz, 1 H), 4.01 (t, J =4 Hz, 2 
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H), 3.65 (s, 3 H), 3.53 (t, J =4 Hz, 2 H), 2.97 (m, 2 H), 2.24 (quintet, J = 4 Hz, 2 H), 1.37 
(s, 9 H)   
Synthesis of p-Bromo-butyl-Boc-OMe-Tyrosine (3). A solution of Boc-Tyrosine-OMe 
(0.500 g, 1 eq, 1.693mmol) was created in acetone (5 mL) in a flame-dried vial. To this 
solution, potassium carbonate (0.702 g, 3 eq, 5.079 mmol) was added, followed by the 
addition of 1,4-dibromobutane (369 μL, 2 eq, 3.383 mmol). The reaction stirred overnight 
at 56℃. It was then cooled to room temperature, filtered into a roundbottom and the 
precipitate in the vial washed with ethyl acetate. The filtrate was then rotovapped. Colum 
chromatography (silica gel, gradient of 7:1 hexanes/ethyl acetate for 10 fractions followed 
by 5:1 hexanes/ehthyl acetate) afforded the desired product as a white crystal (342mg, 
0.795 mmol, 46.9% yield). 1H NMR (400 MHz, CDCl3): δ 7.01 (d, J = 8 Hz, 2 H), 6.79 (d, 
J = 8 Hz, 2 H), 4.97 (d, J = 8 Hz, 1 H), 4.52 (d, J = 8 Hz, 1 H), 3.95 (t, J = 4 Hz, 2 H), 3.69 
(s, 3 H), 3.47 (t, J = 4 Hz, 2 H), 3.01 (m, 2 H), 2.04 (m, 2 H), 1.92 (m, 2 H), 1.40 (s, 9 H) 
Synthesis of p-Azido-propyl-Boc-OMe-Tyrosine (5). Dry dimethylformamide (DMF, 5 
mL) was added to a vial containing protected-bromo-propyl tyrosine (synthesized as 
indicated above, 60 mg, 1 eq, 137 mmol) to create a solution containing the bromo-
tyrosine. This bromo-tyrosine solution was then transferred to a flame dried vial, into which 
was added sodium azide (11 mg, 1.2 eq, 165 mmol). The reaction stirred overnight at 56℃. 
The organic layer was mixed with brine and then extracted with methylene chloride (DCM, 
10 mL) and three times. This organic layer was then back extracted with brine (10 mL). 
This organic layer was then dried with magnesium sulfate, filtered, and rotovapped. 
Column chromatography (silica gel, 1:1 hexanes ethyl acetate) afforded the desired product 
as a crystal (32 mg, 0.085 mmol, 61.7% yield). 1H NMR (400 MHz, CDCl3): δ 7.03 (d, J 
49 
 
= 12 Hz, 2 H), 6.82 (d, J = 12 Hz, 2 H), 4.96 (d, J = 8 Hz, 1 H), 4.53 (d, J = 8 Hz, 1 H), 
4.01 (t, J = 4 Hz, 2 H), 3.71 (s, 3 H), 3.46 (t, J = 8 Hz, 2 H), 3.02 (m, 2H), 2.03 (quintet, J 
= 4 Hz, 2 H), 1.41 (s, 9 H). 13C (400 MHz, CDCl3): δ 172.39, 157.71, 155.07, 130.31, 
128.20, 114.51, 79.89, 64.42, 54.49, 52.19, 48.22, 37.44, 28.77, 28.28   
Synthesis of p-Azido-butyl-Boc-OMe-Tyrosine (6). The protected bromo-butyl tyrosine 
(252 mg, 1 eq, 0.586 mmol) was dissolved in a solution of dimethylformamide (12 mL) in 
a flame-dried vial. Sodium azide (76 mg, 2 eq, 1.17 mmol) was then added to the solution. 
The reaction was stirred overnight at 65℃. The organic layer was mixed with brine and 
then extracted with methylene chloride (DCM, 10 mL) and three times. This organic layer 
was then back extracted with brine (10 mL). This organic layer was then dried with 
magnesium sulfate, filtered, and rotovapped. Column chromatography (silica gel, 3:1 
hexanes ethyl acetate) afforded the desired product (132 mg, 0.349 mmol, 57% yield). 1H 
NMR (400 MHz, CDCl3): δ 7.03 (d, J = 8 Hz, 2 H), 6.84 (d, J = 8 Hz, 2 H), 4.97 (d, J = 8 
Hz, 1 H), 4.54 (d, J = 8 Hz, 1 H), 3.95 (t, J = 8 Hz, 2 H), 3.72 (s, 3 H), 3.36 (t, J = 8 Hz, 2 
H), 3.05 (m, 2 H), 1.80 (m, 4 H), 1.43 (s, 9 H). 13C (400 MHz, CDCl3): δ 172.40, 157.90, 
130.28, 114.47, 67.07, 54.51, 52.18, 51.15, 37.43, 28.28, 26.48, 25.74   
Synthesis of p-Alkynyl-ethyl-Boc-OMe-Tyrosine (7). To a flame dried vial, 5 mL of 
DMF and a stir bar were added. Boc-Tyrosine-OMe (295 mg, 1 eq, 1.000 mmol) was added 
without stirring followed by the slow addition of potassium tert-butoxide (337 mg, 3 eq, 
3.000 mmol). The reaction immediately turned dark green. This mixture was allowed to 
stir at 100℃ for 10 mins, then 4-Bromo-1-butyne was added (94 µL, 133 mg, 1 eq, 1.000 
mmol). The mixture immediately turned a lighter, more brownish green. The mixture was 
then capped and allowed to stir at 80 ℃ overnight. Following reaction, 10 mL of brine was 
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then added to the reaction followed by the addition of 10 mL of ether. The aqueous layer 
was then drained and the ether layer was washed with brine (10 mL portions, 3 times). The 
ether layer was collected and then the aqueous layer was back extracted with 10 mL of 
ether. The ether layer was then dried and rotovapped down. Addition and subsequent 
removal of DCM resulted in the formation of precipitate that was the desired product.  
Synthesis of p-Alkynyl-propyl-Boc-OMe-Tyrosine (8). Boc-Tyrosine-OMe (114 mg, 2 
eq, 0.3855 mmol) was added to a flame-dried vial. Cesium carbonate (254 mg, 3 eq, 0.5783 
mmol) was then added, and the solids were dissolved in dry dimethylformamide (3 mL). 
This mixture was then stirred at 100℃ for 20 mins to activate the tyrosine starting material. 
5-Bromo-1-pentyne (20 µL, 1 eq, 0.1927 mmol) was then added to the mixture, as well as 
a spatula tip of potassium iodide. The reaction was then stirred overnight at 100℃. The 
reaction was then cooled to room temperature and washed with brine (10 mL) and ether 
(10 mL). The ether layer was then washed three times with 10 mL portions of brine. The 
brine layer was then backextracted with 10 mL of ether. The organic layers were combined, 
dried with magnesium sulfate, filtered, and rotovapped. Column chromotagrophay (silica 
gel, 5:1 hexanes/ethyl acetate) to yield the desired product as a white crystal (3 mg, 0.008 
mmol, 4.3% yield). 1H NMR (400 MHz, CDCl3): δ 7.02 (d, J = 12 Hz, 2 H), 6.82 (d, J = 
12 Hz, 2 H), 4.95 (d, J = 8 Hz, 1 H), 4.53 (d, J = 8 Hz, 1 H), 4.03 (t, J = 4 Hz, 2 H), 3.71 
(s, 3 H), 3.02 (m, J = 8 Hz, 1 H), 2.39 (t, J = 4 Hz, 2 H), 1.97 (m, J = 8 Hz, 2 H), 1.55 (s, 1 
H), 1.41 (s, 9 H). 13C (400 MHz, CDCl3): δ 172.42, 157.93, 130.26, 127.94, 114.54, 83.46, 
79.89, 68.84, 66.05, 54.50, 52.18, 37.43, 28.28, 28.16, 21.06, 15.15 
Synthesis of p-Alkynyl-butyl-Boc-OMe-Tyrosine (9). Add 10 mL of ether to a flame-
dried round bottom flask. To this, add pyridine (18 µL, 16.2 mg, 0.21 mmol) and 6-hexyne-
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1-ol (342 µL, 300 mg, 3 eq, 3.06 mmol). A reflux bath was set up at 40℃. Phosphorous 
(III) bromide (97 µL, 276 mg, 1 eq, 1.02 mmol) was then slowly added through the reflux 
condenser, producing a white gas and precipitate in the process. The reaction was then 
refluxed for 2 hours. The reaction was then cooled in an ice bath and diluted with 25 mL 
of ether. The organic mixture was then washed twice with a solution of saturated sodium 
bicarbonate (2 portions of 20 mL) and a single wash with brine (20 mL). The organic layer 
was then quickly condensed, to yield a clear, pungent oil that was the 6-Bromo-hexyne 
product (295 mg).  
 A solution of Boc-Tyrosine-OMe (1.089g, 2 eq, 3.69 mmol) in acetone (1 mL) was 
then made in a flame-dried vial. The 6-Bromohexyne product (295 mg, 1 eq, 1.84 mmol) 
was then dissolved in 4 mL of acetone, and all of this was transferred to the vial containing 
the tyrosine solution. To this mixture, cesium carbonate was added (1.802g, 3 eq, 5.53 
mmol). The reaction was then stirred overnight at 60℃. The reaction was then cooled to 
room temperature and filtered into a new round bottom. The precipitate was washed with 
ethyl acetate and the collected filtrate was condensed. Column chromatography (silica gel, 
gradient of 7:1 hexanes/ethyl acetate for 10 fractions, 5:1 hexanes/ethyl acetate for 20 
fractions, and 1:1 hexanes/ethyl acetate for 10 fractions) afforded the desired product as a 
white crystal (62 mg,  0.165 mmol, 9.0% yield). 1H NMR (400 MHz, CDCl3): δ 7.01 (d, J 
= 8 Hz, 2 H), 6.81 (d, J = 8 Hz, 2 H), 4.95 (d, J = 8 Hz, 1 H), 4.53 (d, J = 8 Hz, 1 H), 3.95 
(t, J = 8 Hz, 2 H), 3.70 (s, 3 H), 3.02 (m, 2 H), 2.27 (td, J = 8 Hz, 4 Hz, 2 H), 1.96 (t, J = 4 
Hz, 1 H), 1.90 (m, 2 H), 1.71 (m, 2 H), 1.41 (s, 9 H). 13C (400 MHz, CDCl3): δ 172.42, 
158.04, 130.74, 127.81, 114.49, 84.07, 68.62, 67.19, 52.17, 37.44, 28.29, 25.02, 18.14. 
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General Protocol for Removal of Methyl Protecting Group. To deprotect the N-
terminus of the unnatural amino acids, 500 µL of dioxane and 500 μL of 1M lithium 
hydroxide were added to a vial containing the unnatural amino acid on ice. The vial was 
then stirred at room temperature for 2 hours. The dioxane was evaporated off and 6M 
hydrochloric acid was added to dropwise until a pH of 4 was obtained. The product was 
then extracted with ethyl acetate into a vial, and the organic layer was dried with 
magnesium sulfate and filtered into a new vial. The filtrate was then rotovapped.  
General Protocol for Removal of tert-Butyloxy Protecting Group. To the methyl-free 
unnatural amino acid, 1 mL of 2% trifluoroacetic acid (200 µL trifluoroacetic acid into 10 
mL of DCM) was added on ice to deprotect the C-terminus of the unnatural amino acid. 
The vial was stirred at room temperature for 1 hour, and the DCM was then rotovapped 
off, affording the final deprotected unnatural amino acid, typically in the form of a white 
crystal.  
Synthesis of p-Bromoethyltyrosine (p2BrY, 10). According to the general protocol 
outlined above, 1 was deprotected to yield a white crystalline powder (26 mg, 0.090 mmol, 
~100% yield). 1H NMR (400 MHz, CD3OD): δ 7.11 (d, J = 8 Hz, 2H), 6.82 (d, J = 8 Hz, 
2H), 4.23 (t, J = 4 Hz, 2 H)   
Synthesis of p-Bromopropyltyrosine (p3BrY, 11). According to the general protocol 
outlined above, 2 was deprotected to yield a white crystalline powder (21 mg, 0.069 mmol, 
24.5% yield). 1H NMR (400 MHz, CD3OD): δ 7.10 (d, J = 8 Hz, 2 H), 6.81 (d, J = 8 Hz, 2 
H), 3.57 (t, J = 4 Hz, 2 H), 2.23 (quintet, J = 4 Hz, 2 H). 
Synthesis of p-Bromobutyltyrosine (p4BrY, 12). According to the general protocol 
outlined above, 3 was deprotected to yield a white crystalline powder (58 mg, 0.183 mmol, 
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23.0% yield). 1H NMR (400 MHz, CD3OD): δ 7.09 (d, J = 8 Hz, 2 H), 6.79 (d, J = 8 Hz, 2 
H), 3.94 (t, J = 4 Hz, 2 H), 2.80 (t, J = 8 Hz, 1 H), 1.98 (m, 2 H), 1.86 (m, 2 H)   
Synthesis of p-Azidopropyltyrosine (p3AzY, 14). According to the general protocol 
outlined above, 5 was deprotected to yield a white crystalline powder (21 mg, 0.080 mmol, 
94.1% yield). 1H NMR (400 MHz, CD3OD): δ 7.10 (d, J = 8 Hz, 2 H), 6.81 (d, J = 8 Hz, 2 
H), 4.90 (s, 1 H), 4.16 (t, J = 4 Hz, 2 H), 1.97 (m, J = 4 Hz, 2 H). 13C (400 MHz, CD3OD): 
δ 172.48, 156.15, 128.37, 127.74, 112.49, 109.99, 62.82, 26.91, 25.71 
Synthesis of p-Azidobutyltyrosine (p4AzY, 15). According to the general protocol 
outlined above, 6 was deprotected to yield a white crystalline powder (28 mg, 0.100 mmol, 
30.0% yield). 1H NMR (400 MHz, CD3OD): δ 7.09 (d, J = 12 Hz, 2 H), 6.79 (d, J = 12 Hz, 
2 H), 3.93 (t, J = 4 Hz, 2 H), 1.99 (m, 2 H), 1.87 (m, 2 H). 13C (400 MHz, CD3OD): δ 
172.44, 156.28, 154.78, 128.33, 127.51, 112.44, 77.53, 65.05, 31.13, 27.80, 26.06, 25.71   
Synthesis of p-Alkynylethyltyrosine (p2yneY, 16). According to the general protocol 
outlined above, 7 was deprotected to yield a white crystalline powder (6 mg, 0.026 mmol).  
Synthesis of p-Alkynylpropyltyrosine (p3yneY, 17). According to the general protocol 
outlined above, 8 was deprotected to yield a white crystalline powder (9 mg, 0.036 mmol, 
18.7% yield). 1H NMR (400 MHz, CD3OD): δ 7.53 (d, J = 12 Hz, 2 H), 7.24 (d, J = 12 Hz, 
2 H), 4.44 (t, J = 4 Hz, 2 H), 2.76 (td, J = 8 Hz, 4 Hz, 2 H), 2.63 (t, J = 4 Hz, 1 H), 2.34 (m, 
2 H). 13C (400 MHz, CD3OD): δ 172.44, 128.29, 112.43, 66.93, 64.26, 26.50, 25.67, 12.74 
Synthesis of p-Alkynylbutyltyrosine (p4yneY, 18). According to the general protocol 
outlined above, 9 was deprotected to yield a white crystalline powder (15 mg, 0.057 mmol, 
34.5% yield). 1H NMR (400 MHz, CD3OD): δ 7.09 (d, J = 8 Hz, 2 H), 6.79 (d, J = 8 Hz, 2 
H), 3.93 (t, J = 4 Hz, 2 H), 2.21 (td, J = 8 Hz, 4 Hz, 2 H), 2.18 (t, J = 4 Hz, 2 H), 1.83 (m, 
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2 H), 1.64 (m, 2 H). 13C (400 MHz, CD3OD): δ 172.44, 156.34, 128.25, 127.38, 112.39, 
81.69, 77.48, 66.74, 65.37, 26.34, 25.66, 23.31, 15.78 
General GFP Expression. A pET-GFP-TAG variant plasmid (0.5 L) was cotransformed 
with a pEVOL-pAzF plasmid (0.5 L) into Escherichia coli BL21(DE3) cells using an 
Eppendorf eporator electorporator. The cells were then plated and grown on LB agar in the 
presence of chloramphenicol (34 mg/mL ) and ampicillin (50 mg/mL) at 37 ̊ C overnight. 
One colony was then used to inoculate LB media (4 mL) containing both ampicillin and 
chloramphenicol. The culture was incubated at 37 ̊ C overnight and used to inoculate an 
expression culture (10 mL LB media, 50 mg/mL Amp, 34 mg/mL Chlr) at an OD600 0.1. 
The cultures were incubated at 37 ̊ C to an OD600 between 0.6 and 0.8 at 600 nm, and 
protein expression was induced by addition of pAzF (100 A L, 100 mM) and 20 % 
arabinose (10 A L) and 0.8 mM isopropyl β-D-1-thiogalactopyranoside (IPTG; 10 A L). 
The cultures were allowed to shake at 30 ̊ C for 16-20 h then centrifuged at 5,000 rpm for 
10 minutes and stored at -80 ̊ C for 3 hours. The cell pellet was re-suspended using 500 µL 
of Bugbuster (Novagen) containing lysozyme, and incubated at 37 ̊ C for 20 minutes. The 
solution was transferred to an Eppendorf tube and centrifuged at 15,000 rpm for 10 
minutes, then the supernatant was poured into an equilibrated His- pur Ni-NTA spin 
(Qiagen) column with of nickel resin (200 µL) and GFP was purified according to 
manufacturer’s protocol. Purified GFP was analyzed by SDS-PAGE (BioRad 10% precast 
gels, 150V, 1.5h), and employed without further purification. Protein concentrations were 
determined both by a BCA assay and fluorescence measurements. 
Biological Cu(I)-1,3-dipolar Cycloaddition Reaction. Clicks on azido-tyrosine GFP-
mutants were performed in 1.5mL Eppendorf tubes. To the experimental tube, in order, the 
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following was added: 2 µL of 50mM CuSO4 as the copper(II) source, 20 μL of 5mM 
Tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine (TBTA) as the catalyst ligand, 5 µL of 
azido-tyrosine mutated GFP (with either an ethyl, propyl, or butyl tether) in PBS, 10 μL of 
488-Alexafluorophore (alkyne functionalized), 50 mM of tris(2-carboxyethyl)phosphine 
(TCEP) as the reducing agent, and 11 µL of phosphate buffer solution (PBS, pH = 7.4) to 
bring to a 50 μL volume. Control reactions were performed with 20 µL azido-tyrosine 
mutated GFP samples (either ethyl, propyl, or butyl) and 10 µL 488-Alexafluorophore in 
the absence of the Cu-1,3-dipolar cycloaddition catalysts (CuSO4, TBTA, and TCEP) to 
ensure that successful reactions were not the result of non-specific interactions between the 
protein and fluorophore. The control reaction was brought to 50 μL volume using PBS. All 
mixtures were reacted for 10 hours at 4℃. The whole sample volumes were then transferred 
to concentrator column (10k MWCO, Corning Spin-X) pre wet with PBS and spun at 
maximum speed in a tabletop centrifuge for 2 minutes. They were then washed with 100 
μL portions of PBS and spun for another 2 minutes. This process was repeated for a total 
of seven washes, and the final spin time was adjusted to bring the samples to a 
concentration of ~25 µL (as indicated by the marking on the column).  
Biological Glaser-Hay Coupling. Glaser-Hay couplings on alkyne-tyrosine mutated GFP 
were performed in 1.5mL Eppendorf tubes. To the experimental tube, the following was 
added in order: 3 μL of 50mM CuI as the catalyst, 3 μL 50 mM trimethylethylenediamine 
(TMEDA) as the catalyst ligand, 10 µL of 488-Alexafluorophore (alkyne functionalized), 
20 μL of alkyne-tyrosine mutated GFP (with either ethyl, propyl, or butyl tether) in PBS 
for a total reaction volume of 36 µL. Control reactions were performed with 6 μL PBS, 10 
µL 488-Alexafluorophore (alkyne), and 20 μL of alkyne-tyrosine mutated GFP (with either 
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ethyl, propyl, or butyl tether) to ensure that successful reactions were not the result of non-
specific interactions between the protein and fluorophore. All mixtures were reacted for 4 
hours at 4℃. The whole sample volumes were then transferred to concentrator column (10k 
MWCO, Corning Spin-X) pre wet with PBS and spun at maximum speed in a tabletop 
centrifuge for 2 minutes. They were then washed with 100 μL portions of PBS and spun 
for another 2 minutes. This process was repeated for a total of seven washes, and the final 
spin time was adjusted to bring the samples to a concentration of ~25 µL (as indicated by 
the marking on the column).  
Nucleophilic Substitution of Bromo-Tyrosine Derivatives. Nucleophilic substitutions 
using dansyl-labeled glutathione (d-GSH, courtesy of the Landino lab) were performed in 
1.5 mL Eppendorf tubes. To the experimental tube, the following was added in order: 20 
μL of bromo-tyrosine mutated GFP (with either an ethyl, propyl, or butyl tether) in 20 mM 
imidazole wash buffer, 10 µL of d-GSH which provided a reactive thiol for nucleophilic 
attack, 5 μL of 50 mM TCEP to help reduce any oxidized d-GSH, 5 µL of 250 mM 
imidazole elution buffer to help activate cysteine residues in the d-GSH, and 10 μL of PBS 
to bring the reaction to a 50 µL volume. Control reactions were performed on wild-type 
GFP using the same conditions above. All reactions were vortexed and then reacted for 24 
hours at 4℃. The whole sample volumes were then transferred to concentrator column (10k 
MWCO, Corning Spin-X) pre wet with PBS and spun at maximum speed in a tabletop 
centrifuge for 2 minutes. They were then washed with 200 μL portions of PBS and spun 
for another 2 minutes. This process was repeated for another wash, and the final spin time 
was adjusted to bring the samples to a concentration of ~25 µL (as indicated by the marking 
on the column).  
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Immobilization of Alkynes onto Epoxy Sepharose 6B Resin. Epoxy-activated 6B 
Sepharose (GE Healthcare, 200 mg) was added to a filter syringe and washed with distilled 
water (5 washes, 3 mL). Alkyn-ol (700 µmol) and coupling buffer (3.5 mL, pH 13.0) was 
added to a 15 mL tube followed by the resin. The mixture was shaken at room temperature 
for 16 h. The resin was transferred to a filter syringe and washed with coupling buffer 
(4mL). The sepharose was transferred to a 15 mL tube and capped with ethanolamine (3.5 
mL). The resin was incubated at 30 ̊C for four hours then washed in a filter syringe with 
acetate buffer (10 mM) and tris-HCl buffer (pH 4 and pH 8 respectively, 3 alternating 
washes with 3 mL each). 
Immobilization of Azido-Tyrosine Mutated GFP Series. All azido-tyrosine GFP 
mutants were brought to a final concentration of 0.250 mg/mL using PBS. To a 1.5 mL 
Eppendorf tube, 15 µL of each azido-tyrosine GFP mutant was added (with either an ethyl, 
propyl, or butyl tether). To this, the Cu(I)-1,3-dipolar cycloaddition reaction conditions 
were then added. In the following order, 5 μL of 4 mM TCEP, 6 µL 1 mM CuSO4, 15 μL 
PBS, and 20 µL 5 mM TBTA were then added to the mix. This liquid mixture was then 
vortexed and transferred to a 1.5 mL Eppendorf that contained 15 mg preweighed alkyne-
derivatized sepharose resin. A positive control consisting of the conditions above using p-
azidophenylalanine, which was previously demonstrated to immobilize on the alkyne-
derivatized sepharose resin, was set up.35 A negative control consisting of the condition 
above using wild-type GFP, which should not react with the alkyne-derivatized sepharose 
resin due to the absence of a reactive azide moiety, was set up. All samples were allowed 
to react overnight at 4℃. These were then transferred to spin columns by adding 2, 200 µL 
portions of PBS to the reaction tube to aid in removal. The reaction was then flowed 
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through at 1.1 rcf on a table-top microcentrifuge for 1 minute, and washed two times with 
100 µL portions at 1.1 rcf for 1 minute each. The protein-immobilized sepharose resin was 
then transferred to a clear Eppendorf tube for visualization and fluorescence quantification.  
IV. FUTURE WORK 
IV. A. Condensation Chemistry 
 Ketones and aldehydes represent another functional group that biological systems 
do not inherently possess, and can therefore be manipulated for bioorthogonal chemistry. 
In particular, condensation reactions involving these groups are ideal, as they can occur in 
aqueous environments and under physiological pH and temperature ranges.17 
The oxime ligation represents a condensation reaction involving a ketone and a 
hydroxylamine group. Jencks demonstrated that at neutral pH, the nitrogen attacks the 
carbonyl compound in a rapid fashion, with the rate-limiting step involving the acid-
catalyzed dehydration of the tetrahedral carbon intermediate, releasing a water molecule 
and forming a carbon-nitrogen double bond.44 When the resulting bond (C=N1-X2) has an 
O in the X2 position (as is the case when the nitrogen base is hydroxylamine), the bond 
formed is called an oxime.  
Scheme 13. General Scheme of the Oxime Ligation 
 
The Raines lab explored the hydrolytic stability of this particular carbon-nitrogen 
double bond relative to the hydrazone variant (X2=NR3).45 Both bond types have an 
intrinsic hydrolytic stability, which is important for the bond’s stability in the aqueous 
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environment of a cell. This stability is conferred from the increased negative charge that is 
imparted on the carbon group bonded to N1, which reduces its elecrophilicity. However, 
using pH-dependent rate profiles and titrations, the Raines lab found that oxime form is 
much more stable than the hydrazone form, which they speculated was due to the greater 
resistance of the oxime to protonation (the first step in the hydrolysis of the imine bond is 
the protonation of the X2 group).  
Based on these findings, the oxime ligation between ketones and hydroxylamine 
groups represents another chemistry that can be exploited for bioorthogonal purposes. For 
example, the Schutz lab employed the oxime ligation to conjugate an aminooxy-containing 
dye to a protein containing a ketone UAA.43  
While this method worked, aminooxy containing dyes are rare. A more ideal 
conjugation mechanism would involve the generation of an aminooxy-functionalized UAA 
to ligate with a ketone-containing dye, which are more readily available. Compound 1 
through 3, the protected bromo-tyrosine series, represents an ideal starting point for the 
formation of an aminooxy UAA. The bromine can readily be displaced via a Boc-protected 
hydroxylamine in the presence of base, affording an aminooxy-derivitized tyrosine 
containing alkyl chains of varying lengths. I have already performed this reaction using 
compound 3, and following column chromatography, obtained the p-Aminooxy-butyl-Boc-
OMe-tyrosine in good yield. Future studies will attempt to perform the oxime ligation using 
this UAA and a ketone-containing dye.  
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Scheme 14. General Reaction Scheme for Synthesis of Aminooxy-UAAs 
 
IV. B. Continued Immobilization Trials 
 As discussed previously, GFP mutated with compounds 16 to 18, the 
alkynyltyrosine UAA series, still needs to be immobilized on the alkyne derivitized resin 
via the Glaser-Hay coupling. Additionally, GFP mutated with compounds 10 to 12, the 
bromotyrosine UAA series, still needs to be immobilized. In order to do this, we propose 
generating an amine derivitzed sepharose resin. This amine can then displace the bromine 
via a nucleophilic substitution reaction, conjugating the GFP to the dye. Future work will 
attempt to generate the amine derivitized sepharose resin, as well as optimize reaction 
conditions for the substitution reaction.  
V. CONCLUSION 
 In conclusion, I was able to synthesize nine, novel UAAs with various functional 
handles and alkyl chains. Furthermore, all UAAs were successfully incorporated into GFP 
using a polyubiquitous aaRS. The novel functional handles present in the UAAs allowed 
me to access different bioorthogonal chemistries. Additionally, the presence of alkyl chains 
of different lengths seemed to successfully distance the site of reaction from the protein 
surface, having differential effects on the outcome of the different bioorthogonal reactions. 
Based on these results, we have demonstrated the potential of UAA-mutagenesis to 
generate unique, site-specific functional handles in proteins for the conjugation of 
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fluorescent dyes. This technology has downstream molecular imaging applications for the 
study of protein dynamics in vivo. 
 Additionally, the UAAs developed here could also be used to generate novel sites 
of immobilization. Our previous immobilization studies only looked at GFP mutated with 
pAzF, a UAA in which the azido functionality comes directly off of the aromatic ring of 
the phenylalanine. We reasoned that the efficiency of the copper click reaction in this 
context was hindered by the bulk of the protein immediately surrounding the functional 
handle. By extending the functional handles off of the protein surface with alkyl chains of 
different lengths, we were able to improve immobilization efficiency in the case of the GFP 
mutated with p2AzY, p3AzY, and p4AzY. The best efficiency came from the p3AzY-
mutant, which interestingly paralleled the click efficiencies with the fluorescent dye 
experiments (see Figures 8 and 13). Thus, the two-carbon alkyl linker may be too sterically 
hindered for access by the reaction partner. Likewise, the four-carbon alkyl linker may be 
too flexible, preventing the functional handle from orienting in the proper fashion for 
reaction with the reaction partner.  
 Overall, the UAAs described represent a novel means to both probe biological 
systems as well as improve current immobilization technologies.  
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CHAPTER 3: DEVELOPMENT OF RAPID MICROWAVE-MEDIATED AND 
LOW-TEMPERATURE BACTERIAL TRANSFORMATIONS 
 
 
I. INTRODUCTION 
 Due to the requisite for substantially high bacterial transformation efficiencies 
(currently the upper limits of ~109) for the creation of a synthetase plasmid library for the 
evolution of aminoacyl-tRNA synthetases, our lab sought to generate a more efficient 
transformation technology. Ideally, this novel methodology could potentially increase 
efficiency while decreasing overall cost, in terms of time producing competent cells and 
technical equipment, of the transformation.  
 Current bacterial transformation techniques can be summed up as a series of three 
basic steps.46 In the first step, bacteria cells are made competent for the introduction of 
foreign genetic material, typically in the form of a plasmid. Next, some kind of physical 
shock, either in temperature or voltage, is applied to the cells to allow for the passage of 
DNA across the membrane. Finally, the cells are recovered for about an hour before 
undergoing a selection process.  
 Typical DNA transformations involve one of two approaches.46,47 Perhaps the least 
technologically sophisticated are chemical transformations. These involve the pretreatment 
of cells with calcium chloride. As a consequence of its negatively charged phosphate 
backbone, DNA is repelled by the hydrophobic core of the bacteria’s phospholipid cell 
membrane. The presence of the divalent calcium cation helps to mitigate the negative 
charge of the DNA, increasing its propensity for passage across the membrane. Next, the 
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cells are placed on ice, which slows down the random motion of the phospholipid bilayer. 
The cells then undergo a heat shock for 50 seconds at 42℃. It is speculated that the rapid 
change in temperature causes “pores” to expand in the membrane, which allow for the 
passage of the calcium-DNA complex into the cell. chemical transformations have been 
shown to have transformation efficiencies ranging from 105 to 109 colony-forming-units 
(cfu). 
 Another DNA transformation technique is electroporation, which requires 
specialized cell stocks and equipment.46–48 In the first step, bacterial cells are prepared for 
electrical shock treatment via the removal of any conducting ions from the cell media and 
the concentration of cells in glycerol. Once prepared, the cells are then subjected to high 
energy electrical pulses (5-10 kV/cm for 5-10 µs), resulting in the transient formation of 
pores in the cell membrane for the transport of plasmid DNA. The cells are then allowed 
to recover from the stress and subjected to a selection procedure. Electorporation 
techniques have led to transformation efficiencies as high as 1010 cfu.48,49  
 While both approaches have been revolutionary in aiding the progress of molecular 
biology, they have their limitations. First, both require the costly and somewhat time-
extensive preparation of cells prior to transformation.46 Second, both require specialized 
equipment that can either reliably control temperatures (for chemical transformations) or 
deliver precise electrical pulses (electroporation). Finally, while both techniques have high 
transformation efficiencies, their upper limits dictate the maximum size of a plasmid 
library. Particularly  in approaches  such as ours, where the generation of a larger library 
would be ideal for the evolution of more suitable synthetases for specific UAAs, this can 
be huge impediment in the speed at which science occurs.  
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 In particular, our lab is interested in the application of microwave technology for 
biological approaches. Microwaves are oscillating electromagnetic fields with wavelengths 
in the range of 1 mm to 1 m and frequencies of 0.3 to 300 GHz.50 It is hypothesized that 
the electric field portion of the microwave irradiation is capable of heating materials 
through a phenomenon known as “microwave dielectric heating.” According to this 
hypothesis, the electric portion of the microwave field interacts with the dipolar 
polarization of a molecule. As the field oscillates, it causes the dipole within the molecule 
to oscillate as well, in an effort to realign with the electric field. However, due to the 
frequencies within the microwave region, the electric field oscillates too quickly for the 
molecule to realign with the field. As a result, the molecule has a phase difference between 
the orientation of its dipole and that of the electric field, producing heat in the form of 
energy lost from the dipole due to molecular collisions and friction. This heating is called 
dielectric heating. 
 Based on these principles, the key to microwave effects is presence of a dipole 
moment within the molecule. Due to the large abundance of polar molecules that comprise 
the cell membrane, especially phospholipids with a polar head group, our lab was interested 
in investigating the potential of microwave technology towards the application of 
microwave-mediated bacterial transformations. 
Recent reports have already investigated the ability of traditional microwaves 
(those found in a kitchen for example) to replace a water bath as the “heat shock” during 
transformations.51 The literature does report a three-fold increase in transformation 
efficiency when employing 1-minute pulses at 180 W; however, the cells used in these 
studies were pretreated with calcium chloride to increase competency. Compared to 
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conventional microwaves, microwave reactors can deliver focused and narrow pulses of 
microwave irradiation. Since biological cell membranes are composed of highly 
polarizable phospholipid molecules, and because this is the main obstacle to the uptake of 
exogenous DNA, we hypothesized that it may be feasible to further enhance the utility of 
microwave transformation by replacing the shock with a microwave pulse. Furthermore, 
this strategy could optimize cell viability, as microwave reactors can be chilled prior to 
irradiation.50 This allows for the transmission of microwave energy without the process of 
heating, which results in cell death and decreased efficiency overall. Finally, because 
microwave irradiation directly interacts with cell membrane and other biomacromolecules, 
it may not be necessary to pretreat cells prior to transformation, increasing the utility of 
this approach.  
Additionally, other studies have demonstrated that a freeze-thaw shock can replace 
the more traditional heat shock in transformation protocols.52 As such, we sought to 
investigate the potential of liquid nitrogen shock (-198 ℃)  transformation as a viable 
alternative to current transformation technologies that does not require pretreated cells.  
II. RESULTS AND DISCUSSION 
Initial attempts aimed at generating a microwave-based approach for bacterial 
transformation involved replacing the water-bath heat shock in chemotransformation with 
pulses of microwave irradiation in a CEM Discover microwave reactor. Escherichia coli 
BL21(DE3) strain of cells were grown to stationary phase (OD600 0.5) or log phase (OD600 
3.2) followed by centrifugation and resuspension in either 1:1 LB/water or 1:1 LB/glycerol. 
Cells were then incubated on ice with a pET plasmid containing ampicillin resistance and 
subjected to brief pulses (2 or 5s) of microwave irradiation (50, 100, 150, 200 or 300 W) 
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in the microwave reactor. Following a 1 hr recovery time in LB media, the cells were plated 
on agar plates containing ampicillin. Unfortunately, none of the cells grew. In order to rule 
out that the microwave irradiation was killing the cells, the same microwave pulses were 
performed in the absence of any plasmid and cells were grown on agar plates containing 
no antibiotic. Interestingly, no differential cellular viability was observed, indicating that 
the lack of growth on the previous ampicillin plates was indeed due to a failed 
transformation.  
 Due to the abundance of polarizable ions in the aqueous media that the cells were 
grown up in, the samples were found to rapidly heat in the microwave. We hypothesized 
that this rapid heating caused the double-stranded plasmid to denature, as most DNA 
requires annealing temperatures between 50-65 ℃. As such, linear, single-stranded DNA 
may have been transferred into the cells, which resulted in a failed transformation. 
Moreover, the temperatures attained may have promoted cellular death prior to the 
transformation event.  
 To overcome this limitation of the microwave transformation, we attempted a 
similar transformation procedure in a microwave reactor equipped with a CEM CoolMate 
system. This cooling system uses a microwave-transparent solution to cool the microwave 
reaction vessel to a temperature well below 0 ℃, while still allowing for the input of 
microwave irradiation into the system. We hypothesized that by cooling the transformation 
we could prevent the heat cytotoxicity of the shock, while simultaneously generating an 
oscillating field that could aid in the uptake of DNA across the cell membrane. Using a 
procedure similar to that outlined above, we attempted bacterial transformations of a pET 
plasmid containing ampicillin resistance. First, we used the CoolMate system to cool the 
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transformation to -30 ℃ (~1 mins), followed by brief (10-30 s) pulses of microwave 
irradiation (100, 200, or 300 W). After a 1 h recovery period, the cells were plated on agar 
containing ampicillin. Gratifyingly, colonies were observed, although the overall 
transformation efficiency remained low. The highest transformation efficiency was 
observed using 15 s pulses with 300 W of power, yielding efficiencies of 213 cfu.  
Table 2.. Microwave Assisted Transformation Efficiencies 
 
 In the process of attempting various controls in the absence of microwave 
irradiation at reduced temperatures in order to mimic the microwave temperature profile, a 
rapid freezing of the cells was attempted using liquid nitrogen (-196 ℃). Following 
recovery, this resulted in a surprisingly high transformation efficiency of 104. A literature 
search revealed some protocols that had explored rapid freezing as a means to transform 
cells. Most notably, a report by Takahashi et al attempted a similar freeze-thaw 
68 
 
transformation with non-chemically competent cells, but only obtained efficiencies of ~100 
under optimal conditions. Other reports used competent cells, and replaced the heat shock 
portion of the protocol with the rapid freezing in liquid nitrogen. While these protocols 
were able to report optimal transformation of ~106, most procedures were still 1-2 orders 
of magnitude lower. The fact that our approach appeared to generate similar results without 
the need for the preparation of competent cells made us interested in exploring the potential 
of low-temperature transformations. 
 In order to optimize the results observed in our freeze-thaw transformation, several 
experimental variables were altered including the number of freeze-thaw cycles, the 
temperature of the transformation, the concentration of divalent cations, and the OD600 of 
the bacterial cells. Overall, the most optimal transformation conditions involved the growth 
of cell cultures to an OD600 of 0.5-0.6, followed by concentration and subjection to two 
freeze-thaw cycles directly in liquid nitrogen. Interestingly, the presence of 10 mM Mg2+, 
which should help mask the negative charge on the diphosphate backbone of DNA, 
improving DNA uptake, had no effect on the transformation efficiency. Additionally, the 
use of chemically competent cells did not increase transformation efficiencies either. These 
results combined indicate that the mechanism for DNA uptake is not based on the ionic 
shielding of the charged DNA-backbone. Additionally, the growth phase of the bacteria 
appeared to have an impact on the transformation efficiency, with cells in early stages of 
replication and in stationary phase exhibiting lower overall efficiencies compared to cells 
in log phase. Furthermore, we also observed that increasing the temperature of the freezing 
above -42 ℃ resulted in no transformants. Resuspending the cells in a 10% glycerol 
solution, a cyroprotectant, rather than water also resulted in no transformants. These data 
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combined suggest that the mechanism of transformation in this case is the rapid formation 
of ice crystals, which must disrupt the bacterial cell wall. This “hole” in the wall provides 
a convenient means for the uptake of exogenous DNA. This data was further corroborated 
by the fact that increasing the number of freeze-thaw cycles >2 resulted in decreased 
transformation efficiencies. We hypothesize that this is due to the increased damage 
sustained by the bacterial cell walls.  
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Table 3. Freeze-Thaw Transformation Efficiencies  
 
 Beyond transformation variables, several different plasmids of varying sizes and 
harboring different antibiotic resistances were also tested for their ability to undergo low-
temperature transformation. Gratifyingly, these transformations also yielded consistently 
high transformation efficiencies.  
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 To further verify the presence of foreign DNA in the transformants, as well as the 
retention of cellular function under these conditions, isolation of plasmid and expression 
of a GFP reporter were successfully performed.  
 
Figure 14. Validation of DNA transformation. A) Following either a liquid nitrogen or a microwave transformation of a pET22-GFP 
plasmid, a culture of cells were grown, the plasmid was isolated and digested with EcoRI. Analysis of the digest on an 1% agarose gel 
confirms the presence of the plasmid DNA. B) To further confirm the transformation and the competence of the cells the GFP protein 
was expressed, purified and analyzed via SDS-PAGE. Successful transfer of plasmid DNA, while retaining cellular function is 
demonstrated by the presence of GFP fluorescence 
Furthermore, the ability to perform simultaneous transformation of two plasmids 
using this procedure was found possible, albeit with decreased transformation efficiencies 
(~102), which is to be expected for the uptake of two separate plasmids.  
 Overall, while none of the transformation efficiencies obtained in E. coli were 
comparable to electroporation or chemotransformation (~105 in this case), the fact that this 
protocol obviates the need to prepare competent cells makes it a highly efficient and useful 
technique for virtually any laboratory.  
 Finally, we sought to explore the potential application of both microwave and low-
temperature transformation techniques towards the transformation of Mycobacteria 
smegmatis. This mycobacterium represents a more significant challenge for the 
transformation process, as its cell wall composition is more complex.53 Furthermore, very 
few efficient mechanisms exist for the transfer of genetic material into this organism. 
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Although electroporation protocols have been generated, they still remain highly 
inefficient in comparison.53 Based on mycobacterial involvement in clinical disease, the 
potential to transfer genetic material into the organism represents a huge advancement in 
scientific research.   
 Using identical freeze-thaw conditions as those described above, a pMycVec1 
plasmid was employed towards M. smegmatis freeze-thaw transformation. Gratifyingly, 
the transformation yielded an efficiency of ~103 cfu. While this is lower than the efficiency 
associated with E. coli, this is to be expected as the literature demonstrates that even under 
electroporation conditions, M. smegmatis has efficiencies less than E. coli. Unfortunately, 
the optimal microwave mediated transformation conditions for E. coli were not transferable 
to M. smegmatis. This is not surprising, however, given the already lower transformation 
efficiencies.  
 Thus, we have demonstrated a novel strategy for the efficient and easy 
transformation of exogenous DNA into M. smegatis that requires no additional preparatory 
steps.  
III. EXPERIMENTAL 
Optimized preparation of competent cells. 2xYT media (4 mL) was inoculated with 
Escherichia coli Novagen BL21(DE3) strain of cells and then incubated for 16 h at 37 ℃ 
to stationary phase. The starter culture (1 mL) was then added to fresh 2xYT media (100 
mL) and incubated with vigorous shaking at 37 ℃ and monitored by routine optical density 
measurements on a spectrophotometer at 600 nm to assess bacterial growth. At the desired 
density, the culture was centrifuged at 4,000 rpm for 20 min. The resulting cell pellet was 
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resuspending in either deionized water or glycerol, for a final cell optical density of 27.7. 
The resuspended cells were then aliquoted (100 µL each) and kept on ice.  
Liquid nitrogen transformation. An aliquot of BL21(DE3) cells was kept on ice, and 
plasmid DNA (1 μL, 70 µg) was added. The cells were incubated on ice for 5 mins and 
then submerged in liquid nitrogen for 20 s. After thawing, the cells were either subjected 
to a second freeze cycle or recovered in 2xYT media (500 μL), followed by 1 h of 
incubation at 37 ℃. Cells were then plated on Luria-Bertani (LB) plates containing 
appropriate antibiotics and incubated overnight at 37 ℃. Colonies were counted to assess 
transformation efficiency, and individual colonies from these plates were selected to ensure 
the presence of plasmid DNA.  
Microwave CoolMate transformation. An aliquot of BL21(DE3) cells was kept on ice, 
and plasmid DNA (1 μL, 70 µg) was added. The cells were incubated on ice for 5 mins and 
then placed in a Discover CoolMate vessel. Each sample was cooled in the CoolMate to a 
specific temperature (typically -30℃) before it was subjected to microwave radiation and 
simultaneous cooling. The temperature was monitored using a fiber optic probe, and upon 
the conclusion of a microwave pulse, the sample was removed from the vessel and thawed 
to room temperature. The cells were recovered in 2xYT media (500 µL), followed by 1 h 
of incubation at 37 ℃. Cells were then plated on LB plates containing appropriate 
antibiotics and incubated overnight at 37 ℃. Colonies were counted to assess 
transformation efficiency, and individual colonies from these plates were selected to ensure 
the presence of DNA.  
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IV. CONCLUSION 
 Overall we have demonstrated two novel means to introduce foreign DNA into 
bacterial systems. The freeze-thaw technique in particular obviated the need to generate 
competent cells, cutting down the amount of time and equipment required to transform 
cells. Furthermore, this freeze-thaw approach also represents a new means to introduce 
DNA into hardier bacterial species, such as the Mycobacteria.   
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APPENDIX A: NMR SPECTRA 
 
 
 
p-Bromo-ethyl-Boc-OMe-Tyrosine (1) 
1H NMR (400 MHz, CDCl3) 
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p-Bromo-propyl-Boc-OMe-Tyrosine (2) 
1H NMR (400 MHz, CDCl3) 
 
p-Bromo-butyl-Boc-OMe-Tyrosine (3) 
1H NMR (400 MHz, CDCl3) 
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p-Azido-propyl-Boc-OMe-Tyrosine (5) 
1H NMR (400 MHz, CDCl3)  
 
13C NMR (400 MHz, CDCl3) 
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p-Azido-butyl-Boc-OMe-Tyrosine (6) 
1H NMR (400 MHz, CDCl3) 
 
13C NMR (400 MHz, CDCl3) 
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p-Alkynyl-propyl-Boc-OMe-Tyrosine (8) 
1H NMR (400 MHz, CDCl3) 
 
13C NMR (400 MHz, CDCl3) 
 
 
 
 
 
 
 
 
80 
 
p-Alkynyl-butyl-Boc-OMe-Tyrosine (9) 
1H NMR (400 MHz, CDCl3) 
 
13C NMR (400 MHz, CDCl3) 
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p-Bromoethyltyrosine (p2BrY, 10) 
1H NMR (400 MHz, CD3OD) 
 
p-Bromopropyltyrosine (p3BrY, 11) 
1H NMR (400 MHz, CD3OD) 
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p-Bromobutyltyrosine (p4BrY, 12) 
1H NMR (400 MHz, CD3OD) 
 
p-Azidopropyltyrosine (p3AzY, 14) 
1H NMR (400 MHz, CD3OD) 
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13C NMR (400 MHz, CD3OD) 
 
p-Azidobutyltyrosine (p4AzY, 14) 
1H NMR (400 MHz, CD3OD) 
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13C NMR (400 MHz, CD3OD) 
 
p-Alkynylpropyltyrosine (p3yneY, 13) 
1H NMR (400 MHz, CD3OD) 
 
 
 
 
 
 
 
 
85 
 
13C NMR (400 MHz, CD3OD) 
 
p-Alkynylbutyltyrosine (p4yneY, 13) 
1H NMR (400 MHz, CD3OD) 
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13C NMR (400 MHz, CD3OD) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
87 
 
ACKNOWLEDGEMENTS 
I’d like to thank my family, who has supported me in everything that I do. 
 
I’d like to thank Valerie Tripp, who mentored me when I first joined the Young Lab and 
was fundamental in developing my laboratory technique 
 
I’d like to thank Jackie McKenna, whose work on this project helped jumpstart this 
project. She was also an amazing hoodmate. 
 
I’d like to thank Matt Freedman, who helped me make and purify various UAAs. 
 
I’d like to thank Benjamin Raliski, who provided constant moral support and was an 
amazing sounding board when experiments were not working. His ideas helped push this 
project forward. 
 
I’d like to thank Jordan Villa and Jessica Lampkowski, who helped console me in lab 
when experiments were not working. 
 
I’d like to thank Ryan Tyler, who was instrumental in keeping me calm throughout this 
process. 
 
I’d like to thank the members of my Honors committee, Dr. McNamara, Dr. Landino, and 
Dr. Forsyth, all of whom have been instrumental in helping me better understand how the 
world works and in inspiring within me an interest in science. 
 
I’d like to thank Dr. Doug Young, who saw potential within me that I didn’t even know 
existed. He constantly believed in me even when I didn’t. The opportunity to work under 
him has been a life-changing experience, and has inspired within me a deep interest in 
cience.   
 
 
 
 
 
 
 
 
88 
 
REFERENCES 
1. Berg, J. M., Tymoczko, J. L., Gatto, G. J. & Stryer, L. Biochemistry. (MacMillan, 
2015). 
2. Nguyen, Q. T. & Tsien, R. Y. Fluorescence-guided surgery with live molecular 
navigation--a new cutting edge. Nat. Rev. Cancer 13, 653–62 (2013). 
3. Young, T. S. & Schultz, P. G. Beyond the canonical 20 amino acids: Expanding 
the genetic lexicon. J. Biol. Chem. 285, 11039–11044 (2010). 
4. Zhu, H. & Snyder, M. Protein chip technology. Curr. Opin. Chem. Biol. 7, 55–63 
(2003). 
5. Rusmini, F., Zhong, Z. & Feijen, J. Protein immobilization strategies for protein 
biochips. Biomacromolecules 8, 1775–1789 (2007). 
6. Tan, W. et al. Optical protein sensor for detecting cancer markers in saliva. 
Biosens. Bioelectron. 24, 266–271 (2008). 
7. Jokerst, J. V. et al. Nano-bio-chips for high performance multiplexed protein 
detection: Determinations of cancer biomarkers in serum and saliva using quantum 
dot bioconjugate labels. Biosens. Bioelectron. 24, 3622–3629 (2009). 
8. Liu, C. C. & Schultz, P. G. Adding new chemistries to the genetic code. Annu. 
Rev. Biochem. 79, 413–444 (2010). 
9. Wang, L., Xie, J. & Schultz, P. G. Expanding the genetic code. Annu. Rev. 
Biophys. Biomol. Struct. 35, 225–249 (2006). 
10. Cornish, V. W. & Schultz, P. G. Mutagenesis an. (1995). 
11. Martin, a B. & Schultz, P. G. Opportunities at the interface of chemistry and 
biology. Trends Cell Biol. 9, M24–M28 (1999). 
12. Strable, E. et al. Unnatural amino acid incorporation into virus-like particles. 
Bioconjugate … 866–875 (2008). at 
<http://pubs.acs.org/doi/abs/10.1021/bc700390r> 
13. Mehl, R. a. et al. Generation of a bacterium with a 21 amino acid genetic code. J. 
Am. Chem. Soc. 125, 935–939 (2003). 
14. Liu, D. R., Magliery, T. J., Pastrnak, M. & Schultz, P. G. Engineering a tRNA and 
aminoacyl-tRNA synthetase for the site-specific incorporation of unnatural amino 
acids into proteins in vivo. Proc. Natl. Acad. Sci. U. S. A. 94, 10092–10097 (1997). 
89 
 
15. Wang, L., Brock, A., Hererich, B. & Schultz, P. G. Expanding the genetic code of 
E. Coli. Science 292, 498–500 (2001). 
16. Wang, L. & Schultz, P. G. A general approach for the generation of orthogonal 
tRNAs. Chem. Biol. 8, 883–890 (2001). 
17. Sletten, E. M. & Bertozzi, C. R. Bioorthogonal chemistry: Fishing for selectivity in 
a sea of functionality. Angew. Chemie - Int. Ed. 48, 6974–6998 (2009). 
18. Borges, C. R. & Watson, J. T. Recognition of cysteine-containing peptides through 
prompt fragmentation of the 4-dimethylaminophenylazophenyl-4’-maleimide 
derivative during analysis by MALDI-MS. Protein Sci. 12, 1567–1572 (2003). 
19. Kalia, J. & Raines, R. T. Catalysis of imido group hydrolysis in a maleimide 
conjugate. Bioorganic Med. Chem. Lett. 17, 6286–6289 (2007). 
20. Huisgen, R. Kinetics and Mechanism of 1,3-Dipolar Cycloadditions. Angew. 
Chemie Int. Ed. English 2, 633–645 (1963). 
21. Rostovtsev, V. V., Green, L. G., Fokin, V. V. & Sharpless, K. B. Supporting 
Information for ‘ A Stepwise Huisgen Cycloaddition Process Catalyzed by Copper 
( I ): Regioselective Ligation of Azides and Terminal Alkynes ’. Angew. Chemie 
Int. Ed. English 114, 2708–2711 (2002). 
22. Tornøe, C. W., Christensen, C. & Meldal, M. Peptidotriazoles on solid phase: 
[1,2,3]-Triazoles by regiospecific copper(I)-catalyzed 1,3-dipolar cycloadditions of 
terminal alkynes to azides. J. Org. Chem. 67, 3057–3064 (2002). 
23. Himo, F. et al. Copper(I)-catalyzed synthesis of azoles. DFT study predicts 
unprecedented reactivity and intermediates. J. Am. Chem. Soc. 127, 210–216 
(2005). 
24. Chan, T. R., Hilgraf, R., Sharpless, K. B. & Fokin, V. V. Polytriazoles as 
copper(I)-stabilizing ligands in catalysis. Org. Lett. 6, 2853–2855 (2004). 
25. Agard, N. J., Prescher, J. a & Bertozzi, C. R. A Strain-Promoted [ 3 + 2 ] Azide - 
Alkyne Cycloaddition for Covalent Modification of Biomolecules in Living 
Systems. 15046–15047 (2004). 
26. Baskin, J. M. et al. Copper-free click chemistry for dynamic in vivo imaging. 
Proc. Natl. Acad. Sci. U. S. A. 104, 16793–16797 (2007). 
27. Siegrist, M. S. et al. D-amino acid chemical reporters reveal peptidoglycan 
dynamics of an intracellular pathogen. ACS Chem. Biol. 8, 500–505 (2013). 
90 
 
28. Swarts, B. M. et al. Probing the mycobacterial trehalome with bioorthogonal 
chemistry. J. Am. Chem. Soc. 134, 16123–16126 (2012). 
29. Glaser, C. Ber. Dtsch. Chem. Ges. 2, 422–424 (1869). 
30. Hay, A. Oxidative Coupling of Acetylenes. II1. J. Org. Chem. 3–4 (1962). 
doi:10.1021/jo01056a511 
31. Vilhelmsen, M. H., Jensen, J., Tortzen, C. G. & Nielsen, M. B. The Glaser-Hay 
reaction: Optimization and scope based on 13C NMR kinetics experiments. 
European J. Org. Chem. 3, 701–711 (2013). 
32. Fomina, L., Vazquez, B., Tkatchouk, E. & Fomine, S. The Glaser reaction 
mechanism. A DFT study. Tetrahedron 58, 6741–6747 (2002). 
33. Lampkowski, J. S., Villa, J. K. & Young, D. D. Development and Optimization of 
Glaser-Hay Bioconjugations. Angew. Chemie Int. Ed. English (pending Revis. 
(2015). 
34. Craggs, T. D. Green fluorescent protein: structure, folding and chromophore 
maturation. Chem. Soc. Rev. 38, 2865–2875 (2009). 
35. Raliski, B. K. et al. Site-Speci fi c Protein Immobilization Using Unnatural Amino 
Acids. (2014). 
36. Tripp, V. T., Lampkowski, J. S., Tyler, R. & Young, D. D. Development of solid-
supported glaser-hay couplings. ACS Comb. Sci. 16, 164–7 (2014). 
37. Chen, X.-H. et al. Genetically Encoding an Electrophilic Amino Acid for Protein 
Stapling and Covalent Binding to Native Receptors. ACS Chem. Biol. (2014). 
doi:10.1021/cb500453a 
38. Xiang, Z. et al. Proximity-enabled protein crosslinking through genetically 
encoding haloalkane unnatural amino acids. Angew. Chemie - Int. Ed. 53, 2190–
2193 (2014). 
39. Young, D. D., Jockush, S., Turro, N. J. & Schultz, P. G. Synthetase polyspecificity 
as a tool to modulate protein function. Bioorganic Med. Chem. Lett. 21, 7502–
7504 (2011). 
40. Deiters, A., Cropp, T. A., Summerer, D., Mukherji, M. & Schultz, P. G. Site-
specific PEGylation of proteins containing unnatural amino acids. Bioorganic 
Med. Chem. Lett. 14, 5743–5745 (2004). 
41. Deiters, A. & Schultz, P. G. In vivo incorporation of an alkyne into proteins in 
Escherichia coli. Bioorganic Med. Chem. Lett. 15, 1521–1524 (2005). 
91 
 
42. Landino, L. M. et al. Fluorescein-labeled glutathione to study protein S-
glutathionylation. Anal. Biochem. 402, 102–104 (2010). 
43. Brustad, E. M., Lemke, E. a., Schultz, P. G. & Deniz, A. a. A general and efficient 
method for the site-specific dual-labeling of proteins for single molecule 
fluorescence resonance energy transfer. J. Am. Chem. Soc. 130, 17664–17665 
(2008). 
44. Sayer, J. M., Peskin, M. & Jencks, W. P. Imine-Forming Elimination Reactions. I. 
General Base and Acid Catalysis and Influence of the Nitrogen Substituent on 
Rates and Equilibria for Carbinolamine Dehydration. J. Am. Chem. Soc. 95, 4277–
4287 (1973). 
45. Kalia, J. & Raines, R. T. Hydrolytic stability of hydrazones and oximes. Angew. 
Chemie - Int. Ed. 47, 7523–7526 (2008). 
46. Sambrook, J. & Russell, D. W. Molecular cloning: a laboratory manual. (Cold 
Spring Harbor Laboratory Press, 2001). 
47. Aune, T. E. V & Aachmann, F. L. Methodologies to increase the transformation 
efficiencies and the range of bacteria that can be transformed. Appl. Microbiol. 
Biotechnol. 85, 1301–1313 (2010). 
48. Neumann, E., Schaefer-Ridder, M., Wang, Y. & Hofschneider, P. H. Gene transfer 
into mouse lyoma cells by electroporation in high electric fields. EMBO J. 1, 841–
845 (1982). 
49. D, H. Studies on transformation of Escherichia coli with plasmids. J Mol Biol 166, 
557–580 (1983). 
50. Collins, J. M. & Leadbeater, N. E. Microwave energy: a versatile tool for the 
biosciences. Org. Biomol. Chem. 5, 1141–1150 (2007). 
51. Fregel, R., Rodríguez, V. & Cabrera, V. M. Microwave improved Escherichia coli 
transformation. Lett. Appl. Microbiol. 46, 498–499 (2008). 
52. Weigel, D. & Glazebrook, J. Transformation of Agrobacterium using the freeze-
thaw method. CSH Protoc 2006, 1031–1036 (2006). 
53. Wards, B. J. & Collins, D. M. Electroporation at elevated temperatures 
substantially improves transformation efficiency of slow-growing mycobacteria. 
FEMS Microbiol. Lett. 145, 101–105 (1996).  
 
